高等真核生物における細胞表面タンパク質のリガンド認識の分子基盤 by 森田 純子 & Morita Junko
 
 
 
 
 
 
学位論文 
 
 
Molecular basis of ligand recognition by cell surface proteins of 
higher eukaryotes 
（高等真核生物における細胞表面タンパク質の 
リガンド認識の分子基盤） 
 
 
平成 29年 12月博士（理学）申請 
 
東京大学大学院理学系研究科 
生物科学専攻 
森田 純子 
 
  
 2 
  
 3 
Abstract 
Cells in multicellular orgaminsms communicate by means of numerous signaling 
molecules. In many cases, these molecules act as ligands that bind to the receptor molecule on 
the surface of the target cells. Elucidating the molecular mechanism of ligand recognition by 
these cell surface receptors helps us to understand biological phenomena of multicellular 
organisms. Here in this dissertation, the ligand recognition mechanism of cell surface proteins 
of higher eukaryotes is described using X-ray crystal structure analysis. 
 
X-ray crystallographic analysis of ENPP6, choline-metabolizing enzyme 
Choline is an essential nutrient for all living cells and is produced extracellularly by 
sequential degradation of phosphatidylcholine (PC). ENPP6, a choline-specific 
phosphodiesterase, hydrolyzes glycerophosphocholine (GPC), a degradation product of PC, as a 
physiological substrate and participates in choline metabolism. ENPP6 is highly expressed in 
liver sinusoidal endothelial cells and developing oligodendrocytes, which actively incorporate 
choline and synthesize PC. ENPP family proteins are conserved extracellular 
pyrophosphatase/phosphodiesterase in vertebrate, and involved in different biological 
processes by hydrolyzing pyrophosphate or phosphodiester bonds in extracellular compounds. 
To understand the molecular mechanism of how ENPP6 recognizes the choline moiety, I 
determined the crystal structure of ENPP6 in complex with phosphocholine at 1.8 Å resolution. 
 The resulting structure revealed that the choline moiety of the phosphocholine is recognized 
by a choline-binding pocket formed by conserved aromatic and acidic residues. The present 
study provides the molecular basis for ENPP6-mediated choline metabolism at atomic, cellular 
and tissue levels. Furthermore, a structural comparison of ENPP6 and other ENPPs offers an 
explanation of why among the family members only ENPP6 specifically recognizes the choline 
moiety of substrates. 
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X-ray crystallographic analysis of the plant receptor-like kinase TDR in complex with the 
peptide hormone TDIF 
In plants, leucine-rich repeat receptor-like kinases (LRR-RKs) perceive ligands, 
including peptides and small molecules, to regulate various physiological processes. TDIF, a 
member of the CLE peptide family, specifically interacts with the LRR-RK TDR to inhibit 
vascular meristem differentiation into tracheary elements, and promotes cell proliferation. 
Here we report the crystal structure of the extracellular domain of TDR in complex with the 
TDIF peptide. The extracellular domain of TDR adopts a superhelical structure comprising 22 
LRRs, and specifically recognizes TDIF by its inner concave surface. Together with the 
biochemical and sequence analyses, the determined structure reveals a conserved 
TDIF-recognition mechanism of TDR among plant species. Furthermore, a structural 
comparison of TDR with other plant LRR-RKs suggested the activation mechanism of TDR by 
TDIF. The structure of this CLE peptide receptor provides insights into the recognition 
mechanism of the CLE family peptides.   
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General Introduction 
Biological functions and cell surface proteins in higher eukaryotes 
In the course of evolution, multicellular organisms did not appear on the Earth until 
unicellular organism had already been in existence for about 2.5 billion years. This is 
accomplished by the ability of cells constituting the whole individual to specialize in different 
functions and cooperate each other. In multicellular organisms, the cells must communicate 
with each other, thereby controlling physiological functions as individuals. Such cell-to-cell 
communication is often mediated by extracellular signal molecules. These molecules include 
proteins, small peptides, amino acids, nucleotides, retinoids, fatty acid derivatives, and even 
dissolved gases. Many of these molecules are 'self' origin, but some are 'non-self' derived 
molecules including PAMPs from pathogens, which triggers host defense reactions such as 
immune responses. In many cases, these molecules are received by receptor molecules on the 
cell surface, which in turn activates intracellular signaling pathway to regulate biological 
events. The signaling systems in higher eukaryotes become much more complicated than those 
in primitive eukaryotes such as yeasts1. For example, the human genome contains more than 
1500 genes that encode receptor proteins, as a result of gene duplication and divergence during 
evolution2. 
Furthermore, multicellular organisms must distribute circulating nutrient 
throughout the cells constituting the individual, as well as take nutrition from outside. To 
achieve this, homeostatic responses maintain circulating nutrients levels constant3. In these 
eukaryotic multicellular organisms, cell surface proteins are responsible in many cases for 
catalysis and uptake of substrates for nutritional metabolism as well as acceptance of 
extracellular signal molecules in target cells. 
 
X-ray crystal structure analysis of cell surface proteins 
Therefore, it is indispensable for maintaining individuals that cell surface proteins 
recognize extracellular signal molecules and external nutrient molecules. Such cell surface 
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proteins are often transmembrane proteins or extracellular proteins attached to the cell 
membrane through electrostatic, hydrophobic, and other non-covalent interactions4,5. Some 
extracellular proteins are post-translationally modified to have fatty acid or prenyl chains, or 
GPI (glycosylphosphatidylinositol), which will be anchored in the lipid bilayer6. Cell surface 
proteins perceive ligands through their extracellular domains to generate intracellular signal, 
which enables cell to alter the behavior of the cell or take up nutrients. Thus, understanding 
the ligand recognition mechanism of cell surface proteins is necessary to understand 
multicellular orgamisms. 
 By determining the complex structure of the cell surface protein and its ligand by 
X-ray crystallography, the structural basis of such a recognition mechanism can be clarified 
with near-atomic resolution. However, it is difficult to use a prokaryotic expression system, 
which is easy to handle with, for the expression of proteins for X-ray crystallographic analysis, 
as eukaryotic cell surface proteins have the following characteristics. 
In order for proteins translated within cells to be transported to extracellular regions, 
it is necessary to have secretory signal sequences in very first amino acids at the N-terminus of 
the polypeptide chain. The secretory signal peptide directs the polypeptide chain to the 
translocation apparatus of the endoplasmic reticulum (ER), which enables protein to be located 
in the correct position outside the cell7. Some of the proteins that are exposed to the external 
side of the membrane are called glycoproteins because they have carbohydrates attached to 
their outer surfaces. Glycosylation occurs in sequence-specific manner in the ER and Golgi 
apparatus. Glycosylation makes the protein more polar, which contributes to its stability and 
solubility8. Another structural feature of cell surface protein to survive harsh extracellular 
condition is disulfide bonds. Apart from peptide bonds, disulfide bonds are the most common 
covalent bonds between amino acid residues in proteins. Disulfide bonds promote the 
resistance of the protein to proteases, contribute to the thermodynamic stability of the protein, 
while protecting the reactive thiol group of Cys9. 
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 Complex modifications such as glycosylation and disulfide bonds as described above 
are basically not carried out in prokaryotic expression systems and often eukaryotic expression 
systems are required for X-ray crystallographic analysis. Thus, in the present dissertation, to 
elucidate the ligand recognition mechanism of the cell surface proteins of higher eukaryotes, 
extracellular domain of such proteins are expressed in a secreted form in a eukaryotic 
expression system, and the X-ray crystallographic analysis of the receptor–ligand complex was 
performed. In Chapter 1, crystal structure of ENPP6, an extracellular phosphodiesterase 
preserved in vertebrates was determined in complex with its reaction product, phosphocholine. 
In Chapter 2, X-ray crystallographic analysis of TDR, a plant hormone receptor in complex 
with its ligand TDIF, is described. Based on the obtained structure, mutant analysis and 
structure–sequence comparison, the molecular function was analyzed. 
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Chapter 1 X-ray crystallography of ENPP6, a choline-metabolizing enzyme 
 
１.1 Metabolism of choline 
In 1998, U.S. National Academy of Sciences recognized choline 
(trimethyl-2-hydroxyl-ethylammonium) as an essential nutrient for humans10. Prolonged 
(weeks to months) ingestion of a diet deficient in choline results in hepatic, renal, pancreatic, 
memory and growth disorders11. Choline and its metabolites, assure the structural integrity 
and signaling functions of cell membranes. Choline is predominantly used for the synthesis of 
essential phospholipid components of cell membranes such as phosphatidylcholine (PC) and 
sphingomyelin (SM)12. Choline is also a source of methyl groups in the diet. For example, 
betaine, a choline metabolite, participates in the methylation of homocysteine to form 
methionine. Choline directly affects cholinergic neurotransmission and lipid transport from 
liver. Choline is de novo synthesized from phosphatidylethanolamine (PE) as a form of PC, 
which is catalyzed by PE N-methyltransferase in liver cells13. In contrast, in other cells choline 
is supplied from an outside source through choline-specific transporters expressed on their 
plasma membrane14. Since the amount of choline required is much higher than that 
synthesized by the liver in vivo, choline must be supplied from dietary sources11. 
Phospholipids such as PC or SM in the diet are digested to choline, which is then 
assimilated in the small intestine and transferred to the liver, where it is converted to PC15. PC 
is secreted from the liver and circulates in the blood as a form of lipoprotein, which is 
sequentially degraded to free choline in the circulation16,17. In blood, choline is present in the 
form of choline derivatives such as PC, SM, glycerophosphorylcholine (GPC) and 
lysophosphatidylcholine (LPC) or a free form (free choline)18. PC is the most abundant choline 
source in blood and its concentration is at the mM level. SM and LPC are also major 
choline-containing phospholipids in blood, and their concentrations are at the several hundred 
µ M level19. In contrast, free choline and GPC are minor components and their concentrations 
are only at the several µ M level in the blood and cerebrospinal fluids18. Since de novo synthesis 
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of choline occurs specifically in liver cells, it is reasonable that free choline used by most cells in 
a body originates from choline-containing phospholipids in blood. 
１.1 ENPP family proteins 
ENPP (Ecto-nucleotide pyrophosphate/phosphodiesterase or NPPs) family proteins 
are extracellular enzymes conserved among vertebrates and hydrolyze phosphodiesters in 
biological molecules20,21． In mammals, seven members are characterized as ENPP family 
proteins (ENPP1–ENPP7, Fig 1-1)． While ENPP1–3 consists of two N-terminal somatomedin 
B-like domains, a central phosphodiesterase (PDE) domain and a C-terminal nuclease-like 
domain, ENPP4–7 have only the PDE domain in common. Although the PDE domains of 
ENPPs share high sequences similarities over 30%, they hydrolyze various pyrophosphate or 
phosphodiester bonds in (di)nucleotides and phospholipids, and thereby regulate a range of 
biological processes. For example, ENPP2 (also known as autotaxin, ATX) has 
lysophospholipase D activity and hydrolyzes LPC and other lysophospholipids to generate a 
signaling molecule, lysophosphatidic acid (LPA), which contributes to cell growth and cell 
motility22,23. ENPP1, ENPP3 and ENPP4 hydrolyze nucleotides such as ATP24, UDP-GlcNAc25  
and diadenosine triphosphate (Ap3A)26, and have roles in bone mineralization, regulation of 
sugar chain synthesis and platelet aggregation, respectively. ENPP3, as known as CD203c is 
highly expressed on basophils and hydrolyzes ATP to negatively regulate allergy and 
inflammation27. ENPP7 specifically hydrolyzes sphingomyelin and contributes to sphingolipid 
metabolism in the intestine28. 
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ENPP6 has in vitro phosphodiesterase activities towards choline-containing 
compounds such as GPC29 and O-phosphorylcholine N-acyl ethanolamine30 to produce 
phosphocholine. ENPP6 hydrolyzes only choline-containing lysophospholipids, such as LPC, 
sphingosylphosphorylcholine (SPC), platelet-activating factor (PAF) and lysoPAF, but not other 
lysophospholipids29, suggesting that ENPP6 recognizes the choline moiety of its substrates. 
Recently, crystal structures of ENPP1, ENPP2 and ENPP4 have revealed that the 
insertion loop in the catalytic pocket of the PDE domain determines their substrate 
specificities (Fig. 1-2 A, B) 31–35. ENPP1 and ENPP4 have a nucleotide-binding pocket formed 
by the insertion loop33–35, whereas ENPP2 has an LPC-binding hydrophobic pocket, since it 
lacks the insertion loop (Fig. 1-2 B)31,32. ENPP6 hydrolyzes LPC to generate phosphocholine 
and monoacylglycerol (lysoPLC activity), whereas ENPP2 hydrolyzes LPC to generate LPA and 
choline (lysoPLD activity). This catalytic difference suggested that whereas ENPP2 has a 
hydrophobic pocket that accommodates the acyl chains of LPC substrates32, ENPP6 has an 
active-site pocket that recognizes the choline head group of LPC substrates. However, the 
choline-recognition mechanism of ENPP6 remains unknown because of a lack of structural 
information. 
  
Fig. 1-1 Domain schematic of ENPP family proteins. 
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１.2 Physiological role of ENPP6 
1.2.1 Cellular role of ENPP6 
ENPP6 is expressed in the kidney, brain and liver, and is bound to the plasma 
membrane through its C-terminal glycosylphosphatidylinositol (GPI) anchor29,36. GPC in 
various biological fluids such as blood and cerebrospinal fluids at the several µM level, is 
hydrolyzed to phosphocholine by ENPP6, which is present on the extracellular surface of 
certain cells such as oligodendrocytes and liver sinusoid endothelial cells. The product 
phosphocholine is quickly converted to free choline in various cell types and used as a source 
for synthesis of choline-containing phospholipids such as PC. In conclusion, ENPP6 serves as a 
choline-supplying enzyme (Fig. 1-3). 
AMP
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Fig. 1-2 Structures of ENPP family proteins. A. Multiple amino acid sequence alignment of 
the mouse ENPP family proteins. Insertion sequences are highlighted. B. Active sites of 
the ENPP1 in complex with AMP (PDB ID 4GTW), ENPP2 in complex with 14:0-LPA (PDB 
ID 3NKN) and ENPP4 in complex with AMP (PDB ID 4LQY). Insertion loops are colored 
gold. 
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Fig. 1-3 Functional model of ENPP6 in cells. 
 
1.2.2 Physiological role of ENPP6 in brain 
ENPP6 is an early marker of oligodendrocyte differentiation. It is reported that the 
myelin sheath was less developed in ENPP6 knock out mice than in wild-type mice. Notably, 
myelin is rich in lipids, especially choline-containing phospholipids such as SM37, suggesting 
that ENPP6 is involved in choline metabolism in the brain. In the developing brain, 
oligodendrocytes require large quantities of choline to make lipid-rich myelin. ENPP6 
contributes to supplying choline for oligodendrocytes (Fig. 1-4 A). 
 
 
1.2.3 Physiological role of ENPP6 in liver and kidney 
In the liver, ENPP6 is expressed in sinusoidal endothelial cells, which mediate the 
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Fig. 1-4 Schematic model of ENPP6-mediated metabolism for GPC in oligodendrocyte (A) and 
hepatocyte (B). 
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transfer of substrates between the sinusoidal blood and hepatocytes, and thus are important 
for hepatic function. Like the brain, the liver requires large quantities of choline. ENPP6 knock 
out mice exhibit mild symptoms of fatty liver, the most known symptoms induced by 
choline-deficiency. Consistently, ENPP6 knock out mice were more susceptible to a 
choline-deficient diet and exhibited severe fatty liver phenotypes at the early stage, indicating 
that ENPP6 is involved in choline metabolism in the liver. As liver cells continuously 
synthesize and secrete PC as a form of lipoprotein, ENPP6 appears to have a role in supplying 
choline in the liver (Fig. 1-4 B) 
Similar ENPP6-mediated choline uptake was observed in the kidney. ENPP6 is 
expressed in epithelial cells forming the lumen of the proximal tubules, which is where choline 
in the primary urine is reabsorbed. Thus, it is possible that ENPP6 in the kidney contributes to 
the reabsorption of choline by hydrolyzing GPC in the primary urine. 
 
１.3 Overview of this study 
As described above, ENPP6 is strongly suggested to be responsible for phosphocholine 
production in vivo. In addition, among ENPP family proteins, only ENPP6 specifically 
recognize choline moiety. However, the molecular structure of ENPP6 is unknown and the 
molecular mechanism of choline recognition by ENPP6 remains elusive. 
In this chapter, the crystal structure of ENPP6 in complex with phosphocholine is 
determined at high resolution, providing the structural basis for the choline recognition 
mechanism by ENPP6. Futhermore, a structural comparison of ENPP6 and other ENPPs offers 
an explanation of why among the family members only ENPP6 specifically recognizes the 
choline moiety of substrates.  
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1.4 Material and Methods 
1.4.1 Construction 
 An expression plasmid encoding the catalytic domain (residues 1–421) of mouse 
ENPP6 fused with the C-terminal TARGET tag, which consists of 21 amino acids (YPGQ×5 + 
V) and is recognized by the P20.1 antibody was constructed 38. DNA fragments encoding the 
catalytic domain of mouse ENPP6 were PCR- amplified by PrimeSTAR MAX DNA polymerase 
(TakaRa Bio) using pCAG-GS-ENPP6 as the template. The PCR products were inserted into 
the XbaI and KpnI sites of pcDNA3.1 (Invitrogen), which had been modified to contain a 
C-terminal Tobacco etch virus (TEV) protease cleavage site followed by the TARGET tag 
(referred to as pcD-CW)38. The expression vectors encoding ENPP6 mutants were prepared by 
site-directed mutagenesis using pcD-CW-ENPP6 as the template. The sequences were verified 
by DNA sequencing. 
 
1.4.2 Cell culture and culture condition 
 The wild type and mutants of ENPP6 were expressed as secreted forms in stably 
transfected HEK293S GnT1- cells or transiently transfected HEK293T cells. The cells were 
cultured in DMEM (Dulbecco’s modified Eagle’s medium, Sigma) supplemented with 10%(v/v) 
FBS (Fetal bovine serum, Euro Clone), 1%(v/v) MEM non-essential amino acids (Sigma) and 
1%(v/v) sodium pyruvate solution (Gibco) and were incubated at 37 °C in a humidified 
atmosphere containing 5% CO2. 
 
1.4.3 Generation of stable cell line and protein expression 
 HEK293S GnT1- cells were co-transfected with the expression plasmid and the 
IR/MAR plasmid (Trans Genic Inc.) using the Lipofectamine 2000 reagent (Invitrogen). Stably 
transfected cell lines were established in medium containing 1 mg mL-1 G418 (Nacalai Tesque) 
and 100 mg mL-1 Blasticidin (InvivoGen), and were cloned by a limiting-dilution procedure in 
96-well plates for two weeks. To obtain a single clone secreting a high level of ENPP6, the 
clones were evaluated by measuring the phosphodiesterase activity in culture supernatants 
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using p-nitrophenylphosphorylcholine as a substrate, as described by Sakagami et al29. 
HEK293T cells were transfected with the expression plasmid, using the Lipofectamine 2000 
reagent, and were then cultured on 150 mm dishes for 3 days. 
 
1.4.4 Protein purification 
All purification operations were performed on ice or at 4 °C. The wild type and 
mutants of ENPP6 were purified from the culture supernatants using P20.1-Sepharose resin 
and a Superdex 200 Increase gel-filtration column (GE Healthcare) in essentially the same 
manner as described for ENPP139. The TARGET tag was cleaved by TEV protease before the 
gel-filtration step. For crystallization, the C393A/C412S mutant was purified using the 
P20.1-Sepharose resin followed by TARGET tag cleavage. The protein was further purified by 
chromatography on a HiLoad 16/60 Superdex 200 gel-filtration column (GE Healthcare) in 20 
mM Tris-HCl pH 7.5, 150 mM NaCl, and concentrated to 2 mg mL-1 using an Amicon Ultra-4 
filter 10 kDa MWCO (molecular-weight cutoff; Millipore) and then stored at -80 °C until use. 
The purity and oligomeric state of the protein were assessed by SDS–PAGE in the presence 
(reducing conditions) and absence (nonreducing conditions) of 5% β-mercaptoethanol, and the 
gels were stained with Simply Blue SafeStain (Invitrogen). 
 
1.4.5 Crystallization 
 Initial crystallization screening was performed at 293 K by the sitting-drop 
vapour-diffusion method in an MRC 96-well Crystallization Plate (Molecular Dimensions) 
using the following screening kits: Crystal Screen (Hampton Research), The PACT Suite and 
The JCSG+ Suite (Qiagen) and JBScreen Classic 1, 2, 4 and 5 (Jena Bioscience). Although the 
protein was crystallized in the presence of the inhibitor T1124, no electron density was observed 
for the inhibitor. Thus this structure was refered as an apo form. Crystals of the apo form were 
obtained by mixing 0.1 µl of protein solution (2 mg/mL ENPP6, 2 mM T11, 20 mM Tris-HCl pH 
7.5, 150 mM NaCl) and 0.1 µl of reservoir solution (0.2 M ammonium chloride, 0.1 M sodium 
acetate pH 5.0, 20% PEG 6000). Crystals of ENPP6 in complex with phosphocholine were 
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obtained by mixing 100 nl protein solution (2 mg/mL ENPP6 in 20 mM Tris–HCl pH 7.5, 150 
mM sodium chloride, 0.2 mM zinc sulfate, 10 mM phosphocholine) and 100 nl reservoir solution 
using a Mosquito crystallization robot (TTP Labtech). Initial hits were optimized at 293 K by 
the sitting-drop vapour-diffusion method by mixing 200 nl protein solution and 200 nl reservoir 
solution. 
 
1.4.6 Data collection and structure determination 
Crystals were cryoprotected in reservoir solution supplemented with 25%(v/v) 
ethylene glycol and were flash-cooled in liquid nitrogen. X-ray diffraction data for crystals of 
the apo form were collected at 100 K on beamline BL41XU at SPring-8 (Hyogo, Japan) and 
processed using XDS40. The structure was determined by molecular replacement with 
MOLREP41. The search model was built by the Phyre 2 server42, using the PDE domain of 
mouse ENPP1 (PDB ID 4GTW) as a template. Model building and refinement were performed 
using COOT43 and PHENIX44. X-ray diffraction data for crystals of ENPP6 in complex with 
phosphocholine were collected on the beamline PXI at the Swiss Light Source (Villigen, 
Switzerland) using a Pilatus 6M detector. A data set was collected at a wavelength of 1.278 Å 
with an oscillation angle of 360° (0.1° per frame), an exposure time of 0.1 s per frame and a 
transmission of 10%. Diffraction images were integrated and scaled using XDS40. Molecular 
replacement was performed with MOLREP41, using using the apo form of ENPP6 as a search 
model. The stereochemical qualities of the models were validated by Ramachandran plot 
analysis with the program RAMPAGE45. The data collection and refinement statistics are 
summarized in Table 1.1. 
 
1.4.7 α-GPC-hydrolyzing assay for the ENPP6 mutants 
Site-directed mutagenesis was performed using PrimeSTAR Max DNA Polymerase 
(Takara Bio). The mutants of ENPP6 were expressed as secreted forms in transiently 
transfected HEK293T cells, and then purified as described in 1.4.4. Each ENPP6 protein was 
mixed with α-GPC and calf intestine alkaline phosphatase (20 U/ml) at 37 °C in the presense 
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of 100 mM Tris-HCl (pH 9.0), 5 mM MgCl2, 500 mM NaCl, 0.05% Triton X-100. Aſter 1 h, 
choline produced from α-GPC hydrolysis was detected by an enzymatic photometric method 
using choline oxidase (Asahi Chemical), horseradish peroxidase (Toyobo), and TOOS reagent 
( N -ethyl- N -(2-hydoroxy-3-sulfoproryl)-3-methylaniline; Dojindo Molecular Technologies, Inc.) 
as a hydrogen donor46,47. 
 
1.4.8 Choline incorporation assay 
Choline incorporation assays were performed by Dr. Kuniyuki Kano and Prof. Junken 
Aoki (Tohoku University). 
ENPP6-expressing cells were generated with a retroviral system as follows: Mouse 
ENPP6 and ENPP6 mutant cDNAs were introduced into the retrovirus vector pMXs-IG48. The 
obtained vector was transfected into PLAT-E cells49 (kindly gifted by Dr. Kitamura). 10 mL of 
culture supernatants of PLAT-E cells containing the viruses were collected and filtered 
through a 0.45 µm filter. For infection, the virus stock was added into Rh7777 cells with 
polybrene (Sigma). After twice infection, GFP positive cells were sorted by Cell Sorter SH800 
(Sony). 
Choline incorporation activity was measured using α-GPC in ENPP6-expressing cells 
in DMEM supplemented with 1% lipoprotein-depleted serum (LPDS). LPDS was prepared 
from FBS as described previously50. It is noted that the obtained LPDS does not contain free 
choline or GPC. The cells were incubated with 10 µM D-α-GPC for 24 h and then lipids were 
extracted by methanol. The level of PC was determined by the liquid chromatography–mass 
spectroscopy (LC-MS/MS).  
The LC-MS/MS system consisting of a NANOSPACE SI-2 HPLC (Shiseido Co., Ltd) 
and a TSQ Quantum Ultra triple quadropole mass spectrometer (Thermo Fisher Scientific) 
equipped with a heated ESI source. For analysis of PC and D-PC, they were separated by a 
SILLICA SG80 column (2.0 mm × 150 mm i.d., 5 µm particle size, Shiseido Co., Ltd.) using a 
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gradient of solvent A (5 mM ammonium formate in water) and solvent B (acetonitrile). The 
initial condition was set at 100% B. The following solvent gradient was applied: a 15-min 
gradient to 82.5% B, a 2-min gradient to 30% B, a 2-min gradient to 100% B and hold for 4 min. 
The flow rate was set at 400 µL/min. All compounds were analyzed as [M+H]+ in the positive 
ion mode. The product ions were as follows: m/z 60.2 (choline), m/z 69.2 (D-choline), m/z 104.2 
(α-GPC), m/z 113.2 (D-α-GPC), m/z 184.0 (PC and LPC) and m/z 193 (D-PC). The ratio between 
analyte and internal standard peak area was used for quantification. 
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1.5 Results 
1.5.1 Protein preparation 
Since our group successfully expressed ENPP139 and ENPP232 in HEK293S GnT1- 
cells as soluble secreted proteins, the catalytic domain (residues 1–421) of mouse ENPP6, 
which lacks the C-terminal GPI-anchor signal sequences (residues 422–440), was expressed in 
HEK293S GnT1- cells (Fig. 1-5). However, unlike ENPP1 and ENPP2, the affinity-purified 
ENPP6 protein predominantly eluted in the void volume from the gel-filtration column, with 
two small peaks corresponding to molecular weights of 50 and 100 kDa (Fig. 1-6 A). Reducing 
and nonreducing SDS–PAGE analyses revealed that these three peaks are all composed of 
ENPP6, indicating that ENPP6 exists as a mixture of monomers, dimers and higher-order 
oligomers in solution (Fig. 1-6 B). In addition, these results indicated that the observed 
oligomerization is mediated by intermolecular disulfide linkages. In contrast, when ENPP6 
was expressed in HEK293T cells, the monomeric population of ENPP6 eluted from the   
Fig. 1-5 Multiple sequence alignment of ENPP6. The zinc-coordinating residues, gray triangles; the 
catalytic residue, red triangles; the tyrosine residues in the cholinebinding pocket, light blue 
triangles; the residues hydrogen bonding with the tyrosine residues in the choline-binding pocket, 
light pink triangles; cysteine residues, orange triangles; the N-glycosylated asparagine residues, 
green triangles; the consensus sequences for N-glycosylation, green lines; the predicted C-terminal 
GPI-attachment residue, a purple triangle. The sequence alignment was prepared using 
ClustalW124 and ESPript125. 
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gel-filtration column increased remarkably, with a concomitant decrease in the dimeric and 
higher-order oligomeric populations (Fig. 1-6 A). Given that HEK293S GnT1- and HEK293T 
cells produce proteins with high mannose N-linked glycans and complex N-linked glycans, 
respectively51, these observations indicated that complex N-linked glycosylation is important 
for preventing the disulfide-mediated oligomerization of ENPP6.  
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Fig. 1-6 Oligomeric state of the wild type and mutants of ENPP6. A. Gel-filtration analysis of 
wild-type ENPP6 expressed in HEK293S GnT1- cells and the wild type and C393A/C412S mutant of 
ENPP6 expressed in HEK293T cells. The proteins were purified by P20.1-Sepharose and then 
chromatographed on a Superdex 200 Increase gel-filtration column. WT, wild type. B. SDS–PAGE 
analysis of wild-type ENPP6 expressed in HEK293S GnT1- cells. The fractions indicated by the red 
line in A. were analyzed by SDS–PAGE under reducing and nonreducing conditions. C. Effect of 
N-glycosylation on the oligomeric state of ENPP6. The wild type and N-glycosylation site mutants of 
ENPP6 were expressed in HEK293T cells, purified by P20.1-Sepharose and analyzed by SDS–PAGE 
under reducing and nonreducing conditions. The proteins were detected by the P20.1 antibody. D. 
Effect of the cysteine residues on the oligomeric state of ENPP6. The wild type and cysteine 
mutants of ENPP6 were expressed, purified and then analyzed as in C. The C84A mutant was not 
expressed in HEK293T cells. 
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ENPP6 has four predicted consensus sequences for N-glycosylation [NX(S/T), where 
X is any amino-acid residue other than Pro; Fig. 1-5], and a mass-spectrometric analysis 
confirmed that the four N-glycosylation sites are indeed modified in bovine ENPP636. To 
examine the effects of N-glycosylation on the oligomeric state of ENPP6, the four mutants of 
mouse ENPP6 (N100D, N118D, N341D and N404D) were prepared. Western blotting analysis 
revealed that the monomeric populations of the four mutants were remarkably reduced 
compared with that of the wild type (Fig. 1-6 C), indicating that all four of the N-glycosylation 
modifications are important for preventing the disulfide-mediated oligomerization of ENPP6. 
ENPP6 has five conserved cysteine residues (Cys84, Cys142, Cys154, Cys393 and 
Cys412; Fig. 1-5). Mass-spectrometric analyses revealed that Cys142 and Cys154 of bovine 
ENPP6, which correspond to Cys142 and Cys154 of mouse ENPP6, respectively, form an intra- 
molecular disulfide bond and that Cys414 of bovine ENPP6, which corresponds to Cys412 of 
mouse ENPP6, forms an intermolecular disulfide bond36. These observations suggested that 
Cys412 of mouse ENPP6 is involved in disulfide-mediated oligomerization. To examine the 
effects of these cysteine residues on oligomerization, three mutants of mouse ENPP6 (C84A, 
C393A and C412S) were prepared. Western blotting analysis showed that the C412S mutant 
predominantly exists as a monomer (Fig. 1-6 D), suggesting that Cys412 is involved in the 
disulfide-mediated dimerization. The Western blotting analysis further revealed that the 
expression levels of the C393A and C412S mutants were increased compared with that of the 
wild type (Fig. 1-6 D). We thus expressed the C393A/C412S double mutant in HEK293T cells 
and purified it using P20.1-Sepharose. The C393A/C412S mutant predominantly eluted as a 
monomer from the gel-filtration column (Fig. 1-6 A). The final yields of the wild type and 
C393A/C412S mutant of ENPP6 were 0.25 and 0.5 mg from 0.5 L culture, respectively.  
1.5.2 Crystal structure analysis of ENPP6 
To elucidate the choline recognition mechanism of ENPP6, I attempted to solve the 
crystal structures of ENPP6. The extracellular PDE domain of mouse ENPP6 (residues 24–
415) C393A/C412S mutant showed α-GPC-hydrolyzing activity comparable to the activities of 
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the monomer and dimer of wild-type ENPP6 (Fig. 1-9 C), indicating that neither the oligomeric 
state nor the C393A/C412S mutation affects the enzymatic activity. Thus, the C393A/C412S 
mutant was crystallized in complex with phosphocholine, a reaction product. 
After the initial screening, clustered crystals were obtained under condition No. 8 of 
The PACT Screen [0.2M ammonium chloride, 0.1M sodium acetate pH 5.0, 20%(w/v) PEG 6000; 
Fig. 1-7 A]. The conditions were optimized by adjusting the pH, the concentration of PEG and 
the types of salt in the reservoir solution. It was found that the addition of zinc sulfate 
enhanced the growth of single crystals. Finally, single crystals were obtained under 
crystallization conditions consisting of 0.2 M ammonium chloride, 0.1 M sodium acetate pH 4.5, 
20%(w/v) PEG 6000, 0.2 mM zinc sulfate (Fig. 1-7 B). 
 
The crystal of the C393A/C412S mutant diffracted to 1.8 Å resolution (Fig. 1-7 C) and 
belonged to space group P1, with unit-cell parameters a = 63.7, b = 68.8, c = 69.7 Å, α = 60.6, 
β= 87.0,	γ = 68.1°. The data-collection statistics are summarized in Table 1-1. Assuming the 
presence of two protein molecules (48.5 kDa calculated from the amino-acid sequence) per 
asymmetric unit, the Matthews coefficient (VM) was estimated to be 2.44 Å3 Da-1, with a 
solvent content of 49.5%52. 
100 µm100 µm
A B C
2.0 Å
Fig. 1-7 Crystals and X-ray diffraction image of the ENPP6 C393A/C412S mutant. A. Crystals of 
the ENPP6 C393A/C412S mutant obtained by the initial screening. B. Crystals of the ENPP6 
C393A/C412S mutant obtained under the optimized conditions. C. X-ray diffraction image of the 
ENPP6 C393A/C412S mutant. 
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The crystal structures of the C393A/C412S mutant in complex with phosphocholine 
was determined at 1.8 Å resolution (Fig. 1-8, Fig. 1-9 A, B, Table 1-1). Previous crystal 
structures of ENPP1, ENPP2 and ENPP4 in complex with their reaction products (AMP, LPA 
and AMP, respectively) provided structural insights into their substrate recognition 
mechanisms31–35 (Fig. 1-10). Accordingly, the crystal structure of ENPP6 in the apo form 
(without substrates) was also determined at 2.0 Å resolution (Fig. 1-8 A, C, Fig. 1-11 A, Table 
1-1). Since the two structures are virtually identical (root-mean-square deviation [rmsd] of 0.23 
Å for aligned Cα atoms), I will hereaſter describe the ENPP6–phosphocholine complex 
structure, unless otherwise stated. The structure of the PDE domain of ENPP6 is similar to 
those of ENPP1 (PDB code 4GTW, 32% identity, rmsd of 1.6 Å for aligned 364 Cα atoms)33, 
ENPP2 (PDB code 3NKM, 28% identity, rmsd of 1.7 Å for aligned 340 Cα atoms)32, and ENPP4 
(PDB code 4LR2, 33% identity, rmsd of 1.4 Å for aligned 359 Cα atoms)35 (Fig. 1-10). Although 
electron densities of four glycans linked to Asn100, Asn118, Asn341 and Asn404 are observed 
in the apo form, the electron density of the Asn100-linked glycan was not observed in the 
complex, probably due to the flexibility of the Asn100-linked glycan (Fig. 1-11 A). 
Although C393A/C412S mutant predominantly exists as a monomer in solution, both 
of the ENPP6–PC complex and the apo ENPP6 crystallize as dimers in the same conformations 
(Fig. 1-12 A). The active site of each promoter is located on the outer surface of the dimer and 
these two active sites are spatially independent, in agreement with the biochemical data that 
indicate dimerization of ENPP6 does not affect its enzymatic activity (Figure 1-12 B). 
Consistent with the fact that ENPP6 forms a dimer via the intermolecular disulfide bond 
between Cys412 of the respective monomers53, the two Ser412 in the dimer observed in the 
crystal structure come close to each other (Fig. 1-12 A). Furthermore, dimerization is mediated 
by extensive hydrogen bonding networks between the promoters, and the residues involved in 
this hydrogen bonding and Cys412 are conserved among species (Fig. 1-5). Moreover, the 
C-termini that lead to GPI anchor signal sequences of the two protomers are close to each other. 
These observations implicate that ENPP6 forms a dimer structure found in the crystal 
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structure in vivo and binds to the plasma membrane via GPI anchor (Fig. 1-12 A), although the 
physiological significance of dimerization is unknown. 
As observed in the structures of ENPP1, ENPP2 and ENPP4, two zinc ions are 
coordinated by conserved active-site residues (Fig. 1-9 B). One zinc ion is coordinated by 
Asp193, His197 and His354, while the other is coordinated by Asp32, His241 and the catalytic 
nucleophile Ser71 (Fig. 1-9 B). 
Table 1-1. Data collection and refinement statistics. 
 Apo ENPP6 ENPP6–phosphocholine 
Data collection   
Beamline SPring-8 BL41XU SLS PXI 
Wavelength (Å) 1.282 1.278 
Space group P1 P1 
Cell dimensions   
a, b, c (Å) 64.3, 78.2, 103.6 63.7, 68.8, 69.7 
a, b, g (°) 90.0, 90.0, 114.6 60.6, 87.0, 68.1 
Resolution (Å) 50.0–1.99 (2.02–1.99) 50.0–1.80 (1.91–1.80) 
Rsym 0.188 (0.835) 0.058 (0.624) 
I/sI 6.11 (1.40) 12.8 (1.78) 
Completeness (%) 96.6 (93.7) 93.6 (88.5) 
Redundancy 3.96 (3.99) 3.54 (3.28) 
CC(1/2) 0.99 (0.62) 0.99 (0.75) 
   
Refinement   
Resolutions (Å) 38.9–2.00 (2.01–2.00) 45.6–1.80 (1.87–1.80) 
No. Reflections 120,105 81,806 
Rwork / Rfree 0.167 / 0.206 0.175 / 0.209 
No. atoms   
Protein 12,807 6,439 
Ligand/ion 394 220 
Water 2,048 528 
B-factors (Å2)   
Protein 20.4 31.7 
Ligand/ion 38.5 49.9 
Water 31.1 38.2 
R.m.s. deviations   
Bond length (Å) 0.007 0.007 
Bond angles (°) 0.890 0.906 
Ramachandran plot 
Favored region 
 
97.2% 
 
97.2% 
Allowed region 2.8% 2.8% 
Outlier region 0.1% 0% 
   
PDB ID 5EGE 5EGH 
*Values in parentheses are for the highest-resolution shell.   
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Fig. 1-8 Ramachandran analysis of the ENPP6 structures. A. Ramachandran plots of the apo 
structure. B. Ramachandran plots of the phosphocholine complex structure. C. The residue in the 
outlier region (B. Asp357 in the apo structure) and interacting residue are shown as sticks. The side 
chain of Asp357 is fixed by a intramolecule salt bridge with the side chain of Arg307. 2FO – FC 
electron density map (contoured at 2 σ) is shown in blue mesh. 
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Number of residues in favoured region (~98.0% expected) :  1516  (97.2%)
Number of residues in allowed region (~2.0% expected) :  43  (2.8%)
Number of residues in outlier region :  1  (0.1%)
Number of residues in favoured region (~98.0% expected) :  759  (97.2%)
Number of residues in allowed region (~2.0% expected) :  22  (2.8%)
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Fig. 1-9 Crystal structure of ENPP6. A. Crystal structure of the PDE domain of ENPP6 in complex 
with phosphocholine. N-linked glycans and the phosphocholine are shown as gold and light pink 
sticks, respectively. B. Active site of ENPP6 in complex with phosphocholine. Hydrogen bonds and 
coordinate bonds are shown as dashed gray and yellow lines, respectively. A water molecule is 
shown as a red sphere. The insertion loop is shown in gold and the bound zinc ions are shown as 
gray spheres in A, B. C. α-GPC-hydrolyzing activities of the ENPP6 mutants. D. Choline uptake in 
cultured cell lines that express wild-type or mutant ENPP6 proteins. Data are shown as mean ± 
SEM (n = 3). 
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Fig. 1-10 Structural comparison of the PDE catalytic domains of ENPP1, ENPP2, ENPP4 and 
ENPP6. Crystal structures of the PDE domains of ENPP1 in complex with AMP (PDB ID 4GTW) 
(A), ENPP2 in complex with 14:0-LPA (PDB ID 3NKM) (B), ENPP4 in complex with AMP (PDB ID 
4LQY) (C), and ENPP6 in complex with phosphocholine (D). The bound zinc ions are shown as gray 
spheres, and the active-site residues are shown as sticks. N-linked glycans are shown as gold sticks. 
The “insertion” loops are highlighted in gold. 
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Fig. 1-11 Electron density maps of ENPP6. A. N-linked glycans of apo ENPP6. 2FO – FC electron density 
maps of N-linked glycans (contoured at 1σ) are shown in blue meshes. Water molecules are shown as red 
spheres. The N-acetylglucosamine (NAG) residues of the glycans linked to Asn100, Asn118 and Asn404 
form water-mediated hydrogen bonds with the protein, and a fucose (FUC) residue of the Asn341-linked 
glycan forms direct and water-mediated hydrogen bonds with Arg351 and His198, respectively. These 
observations indicated that the intramolecular interactions between the N-linked glycans and protein 
surface are important for the stability of ENPP6. B. The active site of ENPP6. A simulated annealing FO – 
FC omit electron density map (contoured at 3σ) of phosphocholine is shown in green mesh, and a 2FO – FC 
electron density map (contoured at 2σ) of Tyr72, Tyr75, Tyr157 and Tyr188 is shown in blue mesh. 
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Fig. 1-12 The dimer structure of ENPP6 found in crystals. A. The schematic view of the dimer 
structure of ENPP6. Two protomers are differently colored. The region shown in C is boxed. B. 
α-GPC-hydrolyzing activities of ENPP6. The monomeric fraction and the dimeric fraction were 
collected from the chromatography on a Superdex 200 Increase gel-filtration column. C. A 
magnified view of the interactions between two protomers. Hydrogen bonds are shown as dashed 
gray lines. 
 
1.5.3 Active site of ENPP6 in complex with phosphocholine 
An electron density corresponding to the bound phosphocholine was observed in the 
vicinity of the zinc ions in the catalytic pocket (Fig. 1-11 B). The choline moiety of the 
phosphocholine is accommodated in a choline-binding pocket formed by the side chains of 
Tyr72, Tyr75, Tyr157 and Tyr188, while the phosphate group of the phosphocholine is located 
in the vicinity of the two zinc ions (Figs 1-9 B). Tyr72, Tyr75 and Tyr188 provide π-cation 
interactions with the positively-charged choline moiety. Furthermore, Asp32 and Glu190 
electrostatically interact with the choline moiety. Tyr72 forms a water-mediated hydrogen 
bond with Glu143, while Tyr75/Tyr188 and Tyr157 form direct hydrogen bonds with Asp32 and 
Glu190, respectively, thereby stabilizing the conformation of the choline-binding pocket. In 
addition, Trp139 and Pro140 in the insertion loop (residues 139–157) interact with the side 
Ser412
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C
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chains of Tyr72, Tyr75, Tyr157 and Tyr188. The conformation of the insertion loop is stabilized 
by a disulfide linkage between Cys142 and Cys154. 
In contrast, in the vicinity of the phosphate group of the phosphocholine, ENPP6 has 
a spacious region to accommodate substrates (the glycerol moiety of GPC or the acyl chain of 
LPC, Fig. 1-13). Since this region is spacious, it is difficult to predict the specific binding mode 
of such substrates and argue for the difference in substrate preference between GPC and LPC. 
Further studies will be required to address these issues. 
 
1.5.4α-GPC-hydrolyzing activities of the choline recognition pocket mutants 
To verify the functional significance of the choline-binding pocket, I introduced 
mutations to the C393A/C412S mutant, purified them, and measured their α-GPC-hydrolyzing 
activities. Among the mutants tested, the Y157A mutant was not expressed in the culture 
supernatants of HEK293T cells, which suggests that Tyr157 is essential for correct protein 
folding. The other mutants eluted as a single peak from the gel-filtration column, confirming 
their structural integrity (data not shown). The Y72A, Y75A, Y188A and E190A mutants 
exhibited the remarkably reduced α-GPC-hydrolyzing activities, as compared with the 
wild-type and C393A/C412S mutant proteins (Fig. 1-9 C), confirming the importance of Tyr72, 
Tyr75, Tyr188 and Glu190 for choline recognition. The activities of the C154A mutants were 
Fig. 1-13 Space around the phosphate group of the phosphocholine is shown in surface 
representation (A) and ribbon and stick representation (B). The electrostatic surface potentials  
is colored in in red (contoured from −10 kT/e) to blue (+10 kT/e). 
Phosphocholine Phosphocholine
Asn92
Leu70
Trp353
Pro337 Pro272
Val273
Gln350
Asn92
Glu190
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His354
Tyr93
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A B
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reduced, indicating the importance of the disulfide linkage between Cys142 and Cys154 for the 
choline-binding pocket formation. The Tyr72, Tyr75, Cys142 and Cys154 are evolutionarily 
conserved among ENPP6 proteins, but not among other ENPP family members (Fig. 1-5, Fig. 
1-14), highlighting the importance of the tyrosine residues and the disulfide linkage in the 
insertion loop for choline recognition. The catalytic nucleophile is a serine residue in ENPP6 
(Ser71 in mouse ENPP6), whereas it is a threonine residue in other ENPP family members (Fig. 
1-14 and 1-15 A–D). Indeed, the S71A and S71T mutants of ENPP6 showed almost no 
α-GPC-hydrolyzing activities (Fig. 1-9 C). In the crystal structure, the side-chain Cβ atom of 
Ser71 forms van der Waals interactions with the side chain of Tyr75, and contributes to the 
choline-binding pocket formation (Fig. 1-15 D), suggesting that the side-chain methyl group of 
a threonine residue at this position would generate steric clashes with Tyr75. These 
observations provided a structural explanation for why only ENPP6 has a serine residue as a 
catalytic nucleophile among the ENPP family members. 
1.5.5 Choline uptake in cultured cell lines that express wild-type or mutant ENPP6 proteins 
To examine the physiological significance of choline recognition by ENPP6 for the 
choline metabolism, choline uptake in cultured cells that express wild-type or mutant ENPP6 
proteins were evaluated by Dr. Kuniyuki Kano and Prof. Junken Aoki (Tohoku University). 
Wild-type ENPP6 expressed in cultured hepatomas hydrolyzed α-GPC for the biosynthesis of 
PC (Fig. 1-9 D). In contrast, the mutant ENPP6 proteins, which had impaired 
α-GPC-hydrolyzing activities (Fig. 1-9 C), failed to support such choline metabolism (Fig. 1-9 D). 
Together, structural and mutational analyses reveal that specific recognition of the choline 
moiety of GPC is required for ENPP6-mediated choline metabolism. 
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Fig. 1-14 Multiple amino acid sequence alignment of the mouse ENPP family proteins. The 
zinc-coordinating residues, gray triangles; the catalytic residue, red triangles; the tyrosine 
residues in the cholinebinding pocket, light blue triangles; the residues hydrogen bonding with 
the tyrosine residues in the choline-binding pocket, light pink triangles; cysteine residues, orange 
triangles; the N-glycosylated asparagine residues, green triangles; the residues in the insertion 
loop, orange boxes. 
Tyr75His74Leu213His242
Thr209Thr238
ENPP1 ENPP2 ENPP4 ENPP6
Phospho-
choline
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Fig. 1-15 Catalytic nucleophiles of the ENPP family members. Active sites of ENPP1 in complex 
with AMP (PDB ID 4GTW) (A), ENPP2 in complex with 14:0-LPA (PDB ID 3NKM) (B), ENPP4 in 
complex with AMP (PDB ID 4LQY) (C), and ENPP6 in complex with phosphocholine (D). Ser71 and 
Tyr75 of ENPP6 and corresponding residues in ENPP1, ENPP2 and ENPP4 are shown as 
space-filling models. 
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1.6 Discussion 
1.6.1 Comparison of choline-binding pocket in ENPP6 and other choline binding proteins’ structures 
The aromatic and acidic residues forming the choline-binding pockets are conserved 
completely in ENPP6 proteins from various species (Fig. 1-5) and are also conserved in other 
choline-binding proteins54 (Fig. 1-16). In the crystal structures of ENPP6 and other 
choline-binding proteins, the choline moiety of ligands form π–cation interactions with 
surrounding multiple aromatic residues, with an acidic residue serving as a counterion to the 
positively charged choline moiety. Thus, the present structure of ENPP6 provides a new 
example of the choline recognition mechanism of choline-binding proteins, and reinforces the 
notion that protein of diverse sequences has evolved convergently to recognize the choline 
moiety of their substrates, using choline-binding pockets of a similar structural feature. 
1.6.2 Structural insight into the substrate specificity of ENPP family proteins 
Previously determined crystal structures of ENPP1, ENPP2 and ENPP4 provided 
insights into their substrate recognition mechanisms31–35. A structural comparison of ENPP6 
and other ENPPs offers an explanation of why among the family members only ENPP6 
specifically recognizes the choline moiety of substrates. ENPP1 and ENPP4 hydrolyze 
nucleotide substrates to produce AMP and pyrophosphate26,55. In the crystal structures of 
mouse ENPP1, the adenine base of AMP is recognized by the conserved phenylalanine and 
tyrosine residues (Phe239 and Try322) through stacking interactions (Fig. 1-17 A). Similarly, in 
the crystal structure of mouse ENPP435, the adenine base is recognized by the conserved 
aromatic residues (Phe71 and Try154) through stacking interactions (Fig. 1-17 C). ENPP6 
Tyr72/Tyr157 correspond to ENPP1 Phe239/Tyr322 and ENPP4 Phe71/Tyr154, respectively 
(Fig. 1-17 D). These observations suggested that ENPP6 cannot hydrolyze nucleotide 
substrates, due to steric clashes between the hydroxyl group of Tyr72 and the base moiety of 
nucleotide substrates. 
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Fig. 1-16 Choline recognition by choline-binding proteins (stereo view). A. ENPP6. B. Bacteria 
choline-binding protein (PDB ID 3R6U). C. Bacteria ChoX (PDB ID 2RIN). D. Electric ray acetylcholine 
esterase (PDB ID 2C4H). E. Protist choline kinaes (PDB ID 3C5I). F. Sea hare acetylcholine-binding 
protein (PDB ID 2XZ5). The residues in the choline-binding pocket and the choline-containing 
compounds are shown as blue and light pink sticks, respectively. 
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1.6.3 Structural comparison of ENPP6 and ENPP2 
ENPP2 hydrolyzes LPC into LPA and choline by its lysoPLD activity22, whereas 
ENPP6 hydrolyzes LPC into monoacylglycerol and phosphocholine by its lysoPLC activity. 
Unlike the other ENPP family members, ENPP2 lacks the insertion loop and instead has a 
hydrophobic pocket, which accommodates the acyl chain of LPC substrates32 (Fig. 1-17 B). In 
contrast, ENPP6 has the insertion loop, which occludes a hydrophobic pocket and contributes 
to the formation of the negatively charged choline-binding pocket, which accommodates the 
positively charged choline moiety of LPC (Fig. 1-17 D). These observations indicated that LPC 
binds to the catalytic pockets of ENPP2 and ENPP6 in the reverse orientation, thereby 
explaining their distinct activities for the LPC substrates. 
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Fig. 1-17 Active sites of the ENPP family members. Active sites of ENPP1 in complex with AMP (PDB 
ID 4GTW) (A), ENPP2 in complex with 14:0-LPA (PDB ID 3NKN) (B), ENPP4 in complex with AMP 
(PDB ID 4LQY) (C), and ENPP6 in complex with phosphocholine (D). The structures are shown in 
ribbon representations (top panels) and in electrostatic surface potentials (contoured from −10 kT/e 
[red] to +10 kT/e [blue]) (bottom panels). The bound products are shown as light pink sticks. The 
insertion loops are shown in gold in (A, C, D). 
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1.7 Conclusion 
In this chapter, the crystal structure of the ENPP6–phosphocholine complex was 
determined at 1.8 Å resolution. The structure showed that ENPP6 recognizes the choline 
moiety of phosphocholine, which strongly supports the idea that ENPP6 recognizes the choline 
moiety of its substrates, such as GPC and LPC, and hydrolyzes them to produce 
phosphocholine in a similar manner. Hence, the molecular basis by which ENPP6 is involved in 
the metabolism of choline by is provided (Fig. 1-18). In the crystal structure, the choline moiety 
is recognized by four conserved tyrosine residues and one conserved glutamic acid residue of 
ENPP6 (Fig. 1-9 B). Biochemical and biological analyses confirmed the functional significance 
of the choline-binding pocket for choline recognition (Fig. 1-9 C, D). Also, structural and 
sequence comparison revealed that differences in the substrate specificity of ENPP proteins 
may caused by differences in the structures of substrate-binding pocket, therby exerting 
diverse biological functions. 
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Fig. 1-18 Schematic model for catalityc activity of ENPP6. 
Chapter 2 X-ray crystallographic analysis of the plant receptor-like kinase 
TDR in complex with the peptide hormone TDIF 
 
2.1 CLE peptide signaling in plants 
In plants, small secreted polypeptide hormones mediate the signalling pathways 
betIen cells, and regulate various physiological functions, including the immune response, 
differentiation and growth control56. The CLAVATA3 (CLV3)/ endosperm surrounding 
region-related (CLE) family peptides, encoded by CLE genes, are the most thoroughly studied 
family among these small peptide hormones. The CLE family genes have been found in diverse 
plant species, including dicots, monocots, conifers, mosses and green algae57–59. They are 
expressed in various tissues by developmental and environmental cues and regulate numerous 
biological processes, including the proliferation and differentiation of stem cells, and the 
development of the meristem, the vascular system and the embryo60,61. In Arabidopsis, 32 CLE 
family genes have been identified, and all of them encode pre-pro-proteins with an N-terminal 
signal peptide, a central variable domain, and 14 amino-acid peptides with the conserved CLE 
domain at their C-termini57,62. Then, the C-terminal 12 or 13 amino acids are cleaved by 
processing to yield the mature CLE peptide. As well as native mature CLE peptides, some of 
chemically synthesized CLE peptides are sufficient to have CLE activities.63–65 The CLE 
peptides are secreted into the apoplast, after proteolytic processing and post-translational 
modifications. They mainly interact with the extracellular regions of membrane associated 
leucine-rich receptor kinases (LRR-RKs), thereby triggering intracellular signalling 
cascades57,66. Several ligand–receptor pairs of the CLE family peptides have been identified, 
including CLV3–CLV1 and CLE9/10–BAM161. CLE peptides, corresponding receptors and their 
functions are summarized in Table 2-1. 
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CLE Amino acid sequence Receptors Functions Selected references 
CLV3 RTVPSGHDPLHH 
CLV1, 2, 
CRN,  
RPK2, 
BAM1, 2 
Maintenance of the SAM 
Clark et al. (1993, 1995,1997)67–69 
Kayes and Clark (1998)70 
Brand et al. (2000)71 
Schoof et al. (2000)72 
Kondo et al. (2006)65 
Muller et al. (2008)73 
Ogawa et al. (2008)74 
Ohyama et al. (2009)62 
Guo et al. (2010)75 
Kinoshita et al (2010)76 
Yadav et al. (2011)77 
Betsuyaku et al. (2011)78 
Shinohara & Matsubayashi 
(2013, 2015)79,80 
Ishida et al. (2014)81 
CLE2 RLSPGGPDPQHH CLV1 ? Ogawa et al. (2008)
74 
Ohyama et al. (2009)62 
CLE9 RLVPSGPNPLHN BAM1, 2, 3 ? Shinohara et al. (2012)82 
CLE10 RLVPSGPNPLHN CLV2 Inhibition of protoxylem vessel formation Kondo et al. (2011)
83 
CLE19 RVIPTGPNPLHN CLV2-CRN Maintenance of the RAM 
Casamitjana- 
Martinez et al. (2003)84 
Fiers et al. (2005)85 
Tamaki et al. (2013)86 
Xu et al. (2015)87 
CLE40 RQVPTGSDPLHH ACR4-CLV1 Maintenance of the RAM, stem cell niche 
Hobe et al. (2003)88 
Stahl et al. (2009, 2013)89,90 
CLE41/ 
44/ 
TDIF 
HEVPSGPNPISN TDR/PXY Vascular stem cells maintenance 
Ito et al. (2006)64 
Hirakawa et al. (2008, 2010)66,91 
Etchells & Turner (2010)92 
Whitford et al. (2008)93 
Kondo et al. (2014)94 
CLE42 HGVPSGPNPISN TDR/PXY Vascular bundle maintenance Yaginuma et al. (2011)95 
CLE45 RRVRRGSDPIHN SKM1, 2z, BAM3 
Pollen tube growth, 
root phloem development 
Endo et al. (2013)96 
Depuydt et al. (2013)97 
Rodriguez-Vialon et al. 
(2014, 2015)98,99 
FON2/4 RSVPAGPDPMHH FON1 Maintenance of the floral meristems 
Nagasawa et al. (1996)100 
Chu et al. (2006)101 
Suzaki et al. (2006)102 
     
  
Table 2-1. Known CLE peptides, corresponding putative receptors and their functions. 
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2.2 CLE peptide TDIF and its receptor TDR 
 Tracheary element differentiation factor (TDIF), a CLE family peptide, was first 
isolated from the xylogenic cell culture of Zinnia elegans. TDIF consists of 12 amino acids 
including two hydroxyproline residues, and is encoded by the CLE41 and CLE44 genes in 
Arabidopsis64. TDIF is secreted from the phloem and is perceived by its specific receptor, 
TDR/PXY (TDIF receptor/phloem intercalated with xylem), which is located on the procambial 
cell membrane66. TDR was originally identified as the component that maintains the cell 
polarity required for the orientation of cell division, during vascular development in the 
vascular meristem103. TDR belongs to the LRR-RK class XI subfamily, and consists of the 
extracellular LRR domain and the cytoplasmic kinase domain103. TDR recognizes TDIF by its 
extracellular LRR domain, and activates the intracellular GSK3 pathway to suppress the 
transcription factor BES1, which promotes cellular differentiation into tracheary elements (Fig. 
2-1)94. Simultaneously, TDR activation enhances the transcription of the homeobox genes 
WOX4 and WOX14, which promote procambial cell proliferation91,104. Furthermore, the 
tissue-specific co-overexpression of the TDR–TDIF pair increases wood formation by twofold in 
the aspen tree, suggesting that the modulation of the TDR–TDIF pathway can be applied for 
biomass engineering105. 
 
TDIF
GSK3s
WOX4
 BES1
TDR
Procambial cell
Kinase
domain
Supress xylem
differentiation
Promote cell division
Fig. 2-1 Schematic model for TDIF–TDR signaling pathway 
that controls cell fate determination in procambial cells. 
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2.3 Structures of plant LRR-RKs 
Recently, several crystal structures of plant LRR-RKs in complex with their ligands 
Ire reported. The crystal structures of BRI1 and PSKR1 in complex with brassinolide and 
phytosulfokine, respectively, revealed the recognition mechanism of phytohormones by 
LRR-RKs (Fig. 2-2)106–108. Furthermore, the crystal structures of FLS2 and PEPR1 in complex 
with the bacterial flagella-derived peptide flg22 and the self-derived danger signal Pep1, 
respectively, demonstrated the epitope-recognition mechanism by LRR-RKs involved in the 
immune systems of plants109,110. HoIver, the molecular mechanism of the CLE family peptide 
recognition by LRR-RKs has remained elusive, due to the lack of the crystal structures of 
LRR-RKs in complex with CLE peptides.  
Insertion
domain
Insertion domain
BAK1
BRI1
PSKR1
FLS2
BRI1–Brassinolide–BAK1
(PDB ID: 4M7E)
FLS2–flg22–BAK1
(PDB ID: 4MN8)
(Sun et al., Science, 2013)(She et al., Nature, 2011)
(Wang et al., Nature, 2015)
(Hothorn et al., Nature, 2011)
flg22
PEPR1–Pep1
(PDB ID: 5GR8)
PSKR1–Phytosulfokine
(PDB ID: 4Z5W)
(Tang et al., Cell. Res., 2015)
PEPR1
Pep1
Phytosulfokine
Brassinolide
Fig. 2-2. Structures of plant LRR-RKs. LRR-RKs, co-receptors 
and ligands are colored white, blue and orange, respectively. The 
insertion domain of BRI1 and PSKR1 are colored dark grey. 
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2.4 Overview of this study 
Here, I report the crystal structure of the TDR–TDIF complex. In conjunction with 
the structure-guided functional analysis, structural insights into the mechanism of TDIF 
recognition by TDR are provided. By comparing the structure of TDR–TDIF complex and 
known plant LRR-RK–ligand complex, the conserved structural features and variable 
structural features are revealed. Structure and sequence comparisons provided insights into 
the recognition mechanism of the CLE family peptides by their cognate receptors. 
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2.5 Material and Methods 
2.5.1 Plasmid construction 
DNA fragments encoding the extracellular LRR domain of TDR from Arabidopsis 
thaliana (residues 31–631) are amplified by PCR using pDONR-221-TDR plasmid (gifted from 
Dr. Yuki Kondo and Prof. Hiroo Fukuda, The University of Tokyo) as templates, PrimeSTAR 
MAX DNA polymerase (Takara Bio) and the following primers: 
5′-ATTGTGGGTTCAGCGAAGTTTTCACCTCAACTCTTGTCTCTC-3′ and 
5′-AACTTCCAGGCCGCTATCAGAATTGCAAGGTTTTCCGAC-3′. The PCR products were 
inserted into pFastBac1 vector (Invitrogen), which had been modified to contain a N-terminal 
Hemolin peptide from Hyalophora cecropia (residues 1–18) and a C-terminal HRV3C protease 
cleavage site (LEVLFQGP) followed by a 10×His tag (pHem-HRV3C- His10-TDR; Fig. 2-3). 
Plasmids were generated using In-Fusion methods (Clontech). To improve the solution 
behaviour of TDR, two less-conserved cysteine residues were mutated (C259A/C540S) by a 
PCR-based method using pHem-HRV3C-His10-TDR as templates, PrimeSTAR MAX DNA 
polymerase (Takara Bio) and the following primers: C259A, 
5′-CTTTGACGTTTCCAATGCCAGCCTCTCTGGTTC-3′ and 
5′-GAACCAGAGAGGCTGGCATTGGAAACGTCAAAG-3′; C540S, 
5′-CTTCTCTCTTTGAATCTCAGCCAAAATCATC-3′ and 5′-CTTCTCGCAATGTCCGATG-3′. 
The DNA sequences were verified by DNA sequencing. 
 
2.5.2 Cell culture and protein expression 
 The wild type and mutants of TDR were expressed as secreted forms in Sf9 cells using 
Bac-to-Bac baculovirus expression system methods (Invitrogen). In detail, 
Secretion signal from Hyalophora cecropia Hemolin (1–18)  
31
C259A C540S
631
TDR 10×His
HRV3C protease cleavage signal
Fig. 2-3 Schematic diagram of the TDR crystallization construct 
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pHem-HRV3C-His10-TDR (Wild type or C259A/C540S) plasmids generated in 2.5.1 were 
transformed into DH10Bac competent cells (Thermo fisher scientific) to produce bacmids, 
which were subsequently transfected into Sf9 cells using FuGENE HD transfection reagent 
(Promega) to generate baculoviruses. Sf9 cells were infected with P3 vaculoviruses at a density 
of approximately 2 × 106 cells/mL. After a 72 h incubation at 27 °C, the culture supernatant was 
collected by centrifugation (6,000g, 10 min, 4 °C) and then was supplemented with 1/100 
volume of 1 M Tris-HCl pH 7.5. 
 
2.5.3 Protein purification 
All purification operations were performed on ice or at 4 °C. The culture supernatant 
was filtrated with bottle top filter (Corning) and then incubated with Ni Sepharose excel resin 
(GE Healthcare) overnight. The resin was then washed with buffer consisting of 20 mM 
Tris-HCl, pH 7.5, 500 mM NaCl, and 20 mM imidazole on an Econo-Column (Bio-Rad). The 
bound protein was eluted with buffer consisting of 20 mM Tris-HCl, pH 7.5, 500 mM NaCl and 
500 mM imidazole, and then dialyzed against 20 mM Tris-HCl, pH 7.5 and 150 mM NaCl to 
remove the imidazole. The protein was incubated with Talon cobalt affinity resin (Clontech). 
The resin was washed with buffer supplemented with 20 mM imidazole, and then the protein 
was eluted with buffer supplemented with 300 mM imidazole. The eluted protein was dialyzed 
against 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 20 mM imidazole with HRV3C protease to 
cleave the C-terminal His tag, and then was passed through the Talon column again. The 
eluted protein was dialyzed against 20 mM sodium citrate, pH 5.5, 500 mM NaCl with Endo H 
(NEB) to digest N-linked glycans at 20 °C overnight. To facilitate crystallization, the lysine 
residues of the deglycosylated TDR protein were methylated, as previously described111. In 
brief, the protein was incubated with the dimethylamine-borane complex (ABC) and 
formaldehyde in 50 mM HEPES, pH 7.5, at 4 °C overnight. The methylated TDR protein was 
further purified by gel filtration chromatography on a Superdex 200 Increase 10/300 GL 
column (GE Healthcare) in 20 mM Tris-HCl pH 7.5, 500 mM NaCl, and concentrated to 3 
mg/mL using an Amicon Ultra-4 filter 30 kDa MWCO (Millipore). The purity of the protein was 
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assessed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) under nonreducing 
conditions, and the gels were stained with Simply Blue SafeStain (Invitrogen). 
 
2.5.4 Crystallization 
A mixture of TDR and a chemically synthesized TDIF peptide 
(HEV(Hyp)SG(Hyp)NPISN, Eurofins Genomics) dissolved in DMSO, at a molar ratio of 1:1.5, 
was crystallized at 20 °C by the vapour diffusion method. Initial crystallization screening was 
performed by the sitting-drop vapour-diffusion method in an MRC 96-well Crystallization Plate 
(Molecular Dimensions) using the following screening kits: Crystal Screen (Hampton Research), 
The PACT Suite, The JCSG+ Suite (Qiagen), JBScreen Classic 1, 2, 4 and 5 (Jena Bioscience) 
Memgold (Molecular Demensions) and SaltRX (Hampton Research). Crystals of TDR in 
complex with TDIF peptide were obtained by mixing 100 nl protein solution (3 mg/mL TDR, 75 
µM TDIF, 20 mM Tris-HCl, pH 7.5 and 150mM NaCl) and 100 nl reservoir solution using a 
Mosquito crystallization robot (TTP Labtech). Initial hit was optimized by the hanging-drop 
vapour-diffusion method by mixing 1 µl of protein solution and 1 µl of reservoir solution (4 M 
sodium nitrate, 0.1 M sodium acetate trihydrate, pH 4.8 and 200 mM ammonium sulfate). 
Crystallization conditions were also optimized with the Additive Screen kit (Hampton 
Research). Crystals were cryoprotected in reservoir solution supplemented with 6 M sodium 
nitrate, and were flash-cooled in liquid nitrogen. 
 
2.5.5 Data collection and structure determination 
 X-ray diffraction data were collected at 100 K on the beamline PXI at the Swiss Light 
Source using a Pilatus 6M detector, and processed using DIALS112. The structure was 
determined by molecular replacement with MOLREP41 using truncated FLS2 (residues 56–611, 
PDB ID 4MNA), in which the residues that did not align with TDR were removed, as the initial 
search model. Automated model building was performed with Buccaneer113, and the resulting 
model was manually completed with COOT43. The refinement was performed using 
REFMAC114 and PHENIX44. The stereochemical qualities of the models were validated by 
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Ramachandran plot analysis with the program RAMPAGE45. The data-collection and 
refinement statistics are summarized in Table 2.2. 
 
2.5.6 Mutant protein preparation 
 The TDR mutants were prepared by a PCR-based method, using the expression 
vector encoding the TDR C259A/C540S mutant as the template PrimeSTAR MAX DNA 
polymerase (Takara Bio) and the following primers: F161A, 5′- 
CTTAAAAGTCTTCAATGCGGCCAGCAACAACTTCG-3′ and 5′- 
CGAAGTTGTTGCTGGCCGCATTGAAGACTTTTAAG-3′; S162A, 5′- 
GTCTTCAATGCGTTCGCCAACAACTTCGAAGG-3′ and 5′- 
CCTTCGAAGTTGTTGGCGAACGCATTGAAGAC-3′; D255E, 5′- 
CAAATCTCAAGTACTTTGAAGTTTCCAATGCCAGC-3′ and 5′- 
GCTGGCATTGGAAACTTCAAAGTACTTGAGATTTG-3′; R421A, 5′- 
GCGAATCTCTATGGGCGTTTCGGAGTCAAAAC-3′ and 5′- 
GTTTTGACTCCGAAACGCCCATAGAGATTCGC-3′; R423A, 5′- 
CTCTATGGCGGTTTGCGAGTCAAAACAATCG-3′ and 5′- 
CGATTGTTTTGACTCGCAAACCGCCATAGAG-3′; R421A/R423A, 5′- 
CTCTATGGGCGTTTGCGAGTCAAAACAATCG-3′ and 5′- 
CGATTGTTTTGACTCGCAAACGCCCATAGAG-3′, and the sequences were verified by DNA 
sequencing. Baculovirus generation and protein expression were performed in the same 
manner as that for the TDR C259A/C540S mutant. The mutant proteins were purified using Ni 
Sepharose excel resin, in a similar manner to that for the TDR C259A/C540S mutant. 
 
2.5.7 Pull-down assay 
The biotinylated TDIF peptide (2 µg) (HEV(Hyp)SG(Hyp)NPISN-GSGS-(Ahx)-Biotin, 
Eurofins Genomics) was mixed with 10 µl of Dynabeads M-280 Streptavidin (Life Technologies) 
beads at room temperature for 30 min. The beads were washed with 200 µL of wash buffer (20 
mM Tris-HCl, pH 7.5, 150 mM NaCl) three times. To test the interaction between TDR and 
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TDIF, the purified TDR protein was mixed with the biotinylated TDIF-bound beads in the 
presence of 0.1 mg/mL BSA, and then incubated at 4 °C for 2 h. The beads were then washed 
three times with 200 µL wash buffer. The bound proteins were eluted by boiling in SDS sample 
buffer and analysed by SDS–PAGE. 
	
2.5.8 FRET analysis 
FRET analysis was performed by Dr. Yuki Kond and Prof. Hiroo Fukuda (The 
University of Tokyo). 
Mutated TDR variants were produced by site-directed mutagenesis with the 
pDONR221 vector harbouring TDR. The coding sequences of BIN2 and the mutated TDR were 
transferred from the entry clones into the destination vectors by the LR recombination reaction, 
to generate 35 S-BIN2–YFP and pER8-TDR(mut)-CFP. These expression vectors were 
transformed into the Rhizobium radiobacter strain GV3101 MP90. The cultured agrobacterium 
suspended in infiltration buffer (10 mM MES, 10 mM MgCl2 and 150 µM acetosyringone, pH 
5.7) was injected into Nicotiana benthamiana leaves with a 1 mL syringe (Terumo). After 2 
days of infiltration, the tobacco leaf disks were treated with 10 µM estradiol for 18 h. After 
confirming YFP and CFP expression in the leaf epidermis, the FRET analysis was performed 
according to the acceptor photobleaching method, using an LSM-510 META confocal 
microscope (Carl Zeiss). First, the CFP fluorescent signal intensities at the plasma membrane 
was measured. Subsequently, BIN2–YFP was photobleached with 514 nm laser irradiation at 
the plasma membrane, and then the CFP signal intensities were re-measured. For the 
detection of the CFP fluorescent signal, a 458 nm excitation laser and a 477–520 nm emission 
filter were used. FRET efficiencies were calculated by comparing CFP fluorescent intensities 
before and after photobleaching. 
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2.6 Results 
2.6.1 Structure determination 
Initially, the extracellular domain (residues 31–631) of TDR from Arabidopsis 
thaliana was prepared, using the Sf9-baculovirus expression system and purified (Fig. 2-4). To 
improve the solution behaviour of the TDR extracellular domain, mutations were introduced to 
two less-conserved cysteine residues (C259A/C540S, Fig. 2-3) and performed the crystallization 
screening using the C259A/C540S TDR mutant. I attempted the crystallization screening of 
the complex with a synthesized TDIF peptide (HEV(Hyp)SG(Hyp)NPISN), but no crystals were 
obtained. 
Prediction by the NetNGlyc 1.0 Server115 revealed that 11 N-glycosylation motifs 
(NxS/T) were highly likely to be modified in the extracellular domain of TDR (Fig. 2-5). To 
increase the chance of the quality of crystallization, N-linked glycans of TDR were 
enzymatically digested (Fig. 2-6 A). The resulting change in molecular weight after the 
deglycosylation was detected by as shifts in gel mobility (Fig. 2-6 B). The deglycosylated TDR 
and TDIF yielded crystals that diffracted to around 5 Å, which was not of sufficient quality for 
data collection (Fig. 2-6 C, D). 
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Fig. 2-4 Purification of the extracellular domain of TDR. A. Gel-filtration 
analysis of the extracellular domain of TDR. The proteins were 
chromatographed on a Superdex 200 Increase 10/300 GL column. B. SDS–
PAGE analysis of purified TDR. 
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Fig. 2-5 Potential N-glycosylation sites of the extracellular domain of TDR predicted by 
NetNGlyc 1.0 server. 
A B C
 D
200 µm
(      ) nX
Endo H NAG
Endo H (-)
Endo H (+)
MAN
kDa
75
50
Asn
Y
Fig. 2-6 Enzymatic cleavage of N-linked glycans. A. Cleavage site for Endo H in N-linked 
glycans. NAG, red square; MAN, blue circle. High mannose glycan: (Man)1-2, X, Y.; n=2~150 
Hybrid glycan: AcNeu-Gal-GlcNAc, X and/or Y; n=2. B. Mobility shift analysis of TDR before and 
after Endo H treatment. C. A Crystal of the Endo H-treated TDR C259A/C540S mutant and 
TDIF. D. X-ray diffraction image of the Endo H-treated TDR C259A/C540S mutant and TDIF. 
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Fig. 2-7 Activities of TDR construct used for crystallization. A. Pull-down experiments between 
biotinylated-TDIF and TDR WT and the lysine methylated C259A/C540S TDR mutant. The wild 
type and C259A/C540S mutant of TDR were expressed and purified from Sf9 insect cells, and 
mixed with Streptavidin beads in the presence or absence of biotinylated TDIF. Bound proteins 
were eluted with SDS sample buffer and analyzed by SDS-PAGE. B. Subcellular localization of 
BIN2–YFP and TDR–CFP in N. benthamiana, before and after photobleaching. Areas surrounded 
by red rectangles indicate the regions photobleached by the 514 nm laser. Scale bars indicate 20 
µm. C. Quantification of the fluorescent signals of BIN2–YFP and TDR–CFP in the red rectangle 
areas in B. The relative fluorescent signals were calculated by comparison with the signal before 
photobleaching and are shown as a percentage (%). D. Localization of TDR–CFP variants in 
Nicotiana benthamiana epidermis. Scale bars indicate 20 µm. E. TDIF responses in the TDR 
C259A/C540S mutant. TDIF responses were evaluated by measuring FRET efficiencies between 
TDR–CFP and BIN2–YFP. The boxplot diagram displays the FRET efficiencies upon incubations 
with or without 5 µM TDIF for 30 min. Significant differences according to the Student’s t-test are 
indicated by asterisks (P < 0.01; n = 15). F. Bioactivities of synthetic peptides. TDIF activities of 
synthetic peptides were evaluated by measuring FRET efficiencies between TDR–CFP and BIN2–
YFP. The boxplot diagram displays the FRET efficiencies with 5 µM synthetic peptides applied for 
30 min. Significant differences (P < 0.05) are indicated by distinct letters (Tukey’s test; n = 15). 
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Fig. 2-8. Schematic model of the reconstituted TDR–TDIF 
pathway in Nicotiana benthamiana leaves. 
 
In order to improve the quality of the crystals, lysine residues of TDR were 
methylated as previously described111. A pull-down assay using the biotinylated TDIF peptide 
confirmed that the deglycosylated and lysine methylated C259A/C540S mutant has 
TDIF-binding activity comparable to that of the wild-type protein (Fig. 2-7 A). Furthermore, to 
measure the signalling activity of the C259A/C540S mutant, the TDIF–TDR pathway was 
reconstituted in Nicotiana benthamiana leaves with TDR or its mutants fused with the cyan 
fluorescent protein (TDR–CFP), together with BIN2, a member of GSK3s, fused with the 
yellow fluorescent protein (BIN2–YFP), as previously described94 (Fig. 2-7 B, C, Fig. 2-8, 
performed by Dr. Yuki Kondo and Prof. Hiroo Fukuda). It was confirmed that the 
C259A/C540S mutant TDR localizes to the plasma membrane, similarly to wild-type TDR (Fig. 
2-7 D). Both the wild-type TDR and C259A/C540S mutant showed reduced fluorescence 
resonance energy transfer (FRET) efficiency of TDR–CFP with BIN2–YFP, on the TDIF peptide 
application, indicating that C259A/C540S mutant TDR possesses TDIF responsiveness 
comparable to that of the wild-type protein (Fig. 2-7 E). In addition, the biotinylated TDIF 
peptide used for pull-down assays also reduced the FRET efficiency, indicating that the 
biotinylated TDIF peptide is biologically active (Fig. 2-7 F). 
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YFPCFP
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Thus the C259A/C540S mutant was crystallized TDR in complex with TDIF. After the 
initial screening, crystals were obtained under condition No. 46 of SaltRX Screen [4 M sodium 
nitrate, 0.1 M sodium acetate trihydrate pH 4.6]. Finally, the crystals of the TDR–TDIF 
complex were obtained, which diffracted to 3.0 Å resolution (Fig. 2-9 A, B) and belonged to 
space group P3121, with unit-cell parameters a = b = 132.9, c = 229.8 Å, α = β=	90.0°, γ = 
120.0°. The crystal structure was determined at 3.0 Å resolution by molecular replacement, 
using the structure of the partial extracellular LRR domain of FLS2 (PDB ID: 4MN8) as the 
search model (Fig. 2-10, Table 2-2). 
 
 
200 µm
A
B
Fig. 2-9 Crystals and X-ray diffraction image of the lysine-methylated TDR. A. Crystals obtained 
from methylated TDR in complex with TDIF. B. X-ray diffraction image of the TDR–TDIF complex. 
-180
0
180
-180 0 180
φ
ψ
General/Pre-Pro/Proline Favoured General/Pre-Pro/Proline Allowed
Glycine Favoured Glycine Allowed
Number of residues in favoured region (~98.0% expected) :  572  (94.9%)
Number of residues in allowed region (~2.0% expected) :  31  (5.1%)
Number of residues in outlier region :  0  (0%)
Fig. 2-10. Ramachandran plots of the TDR–TDIF complex structure. 
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 Table 2-2. Data collection and refinement statistics 
  
Data collection  
Beamline SLS PX I 
Wavelength (Å) 1.00 
Space group P3121 
Cell dimensions  
a, b, c (Å) 132.9, 132.9, 229.8 
a, b, g (°) 90.0, 90.0, 120.0 
Resolution (Å) 103–3.00 (3.11–3.00) 
Rsym 0.053 (0.436) 
I/sI 8.8 (1.4) 
Completeness (%) 99.8 (99.9) 
Redundancy 9.7 (10.2) 
CC(1/2) 0.995 (0.800) 
  
Refinement  
Resolutions (Å) 57.6–3.00 (3.06–3.00) 
No. Reflections 47,591 
Rwork / Rfree 0.220 / 0.238 
No. atoms  
Protein 5,089 
Solvent 0 
B-factors (Å2)  
 Protein 80.9 
R.m.s. deviations  
 Bond length (Å) 0.004 
Bond angles (°) 1.210 
Ramachandran plot 
Favored region 
 
94.9% 
Allowed region 5.1% 
Outlier region 0.0% 
  
PDB ID 5GIJ 
  
*Values in parentheses are for the highest-resolution shell.  
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A B
Fig. 2-11 Overall structure of the TDR–TDIF complex. A, B. Ribbon representation (A) and surface 
representation (B) of the crystal structure of the extracellular LRR domain of TDR in complex with 
TDIF. TDIF, N-linked glycans and Cys residues that form disulfide bonds are shown as orange, 
blue and yellow-green sticks, respectively. Two residues mutated from cysteines (Ala259 and 
Ser540) are also shown as sticks. The N-terminal capping domain is coloured dark green. The 
positions of the LRRs are indicated. 
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2.6.2 Overall structure 
The extracellular domain of TDR forms a twisted right-handed superhelix composed 
of 22 LRRs and N-terminal (residues 34–81) and C-terminal (residues 609–637) capping 
domains (Fig. 2-11 A, B). The N-terminal capping domain is assembled from α helices, a β 
strand and a disordered loop (residues 61–64), and is stabilized by a disulfide bond (Cys69–
Cys76; Fig. 2-11 A, B). The C-terminal capping domain is assembled from a 310 helix and a β 
strand, and is stabilized by a disulfide bond (Cys620–Cys629; Fig. 2-11 A). Plant LRR proteins 
typically contain repeat sequences of 20–29 amino acids with an LxxLxLxxNxGxIP consensus 
motif, where X represents any amino acid, and Leu is sometimes substituted by other 
hydrophobic residues, such as Phe or Val116. The known plant LRR-RK structures share the 
inner concave surface, consisting of parallel β strands formed by the LxxLxL motif, while the 
outer convex surface consists of various secondary structures, including α helices, 310 helices 
and short additional β strands106–110,117. The present crystal structure of TDR revealed that 
the repetition of 23–24 amino acids forms the 22 LRR domains (LRR1–LRR22), which compose 
the inner concave surface with the parallel β strands formed by the LxxLxL motif, and the 
outer convex surface with helices or loops formed by variable sequences following the GxIP 
motif (Fig. 2-12). Two loops on the convex surface are stabilized through disulfide bonds formed   
LRR1                 P       V L L G I Q IS D SHRNLS R IQIRYLS   105
LRR2                 P       L L L N G  S LY N SG SLE SF TSIFDLT   129
LRR3                 P       L L I N  K TT D SR SFDSSF PGISKLK   153
LRR4                 P       L A N G L F KVFN FS NFE L SDVSRLR   177
LRR5                 P       L L S G I F EE NFGG YFE E AAYGGLQ   201
LRR6                 P       L I L N G L R KF H AG VLG K PRLGLLT   225
LRR7                 P       L M I N G I E QH E GY HFN N SEFALLS   249
LRR8                 P       L V G L N KYFD SNCSLS S QELGNLS   273
LRR9                 P       L L L N G I N ET F FQ GFT E ESYSNLK   297
LRR10                 P       L L N G I S KL DFSS QLS S SGFSTLK   321
LRR11                 P       L L L N G V N TW S IS NLS E EGIGELP   345
LRR12                 P       L L L N G L E TT F WN NFT V HKLGSNG   369
LRR13                 P       L M V N G I K ET D SN SFT T SSLCHGN   393
LRR14                 P       L L L N G L K YK I FS MFE E KSLTRCE   417
LRR15                 P       L N G I S WRFRSQN RLN T IGFGSLR   441
LRR16                 P       L V L N I N TF D SN RFTDQ ADFATAP   465
LRR17                 P       L L L N L V QY N ST FFHRK ENIWKAP   489
 LxxLxLxxNxLxGxIP
LRR18                 P       L A S G I N QIFS SF NLI E NYVGCK.   512
LRR19                 P       I L N G I SFYR E QG SLN T WDIGHCE   536
LRR20                 P       L L L N G I K LC N SQ HLN I WEISTLP   560
LRR21                 P       I V L N G I S AD D SH LLT T SDFGSSK   584
LRR22
82
106
130
154
178
202 
226
250
274
298
322
346
370
394
418
442
466
490
513
537
561
585                 P       I V N G I T TTFN SY QLI P SGSFAHL   608
concave β-sheet convex α-helix
Fig. 2-12 Sequence alignment of LRRs of TDR. The Cys residues that form disulfide bonds are 
indicated with an orange background, and the glycosylated Asn residues are indicated with a 
green background. The residues that form the concave β sheets and the convex α helices are 
enclosed in magenta and blue boxes, respectively. 
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between adjacent repeats (LRR13–LRR14 and LRR18–LRR19). In the crystal structure, the 
electron densities were observed for the 11 glycan chains attached to the Asn side chains in the 
LRR domains (Fig. 2-11 A, B and Fig. 2-12), although their biological functions are unknown. 
2.6.3 TDIF kink recognition by the TDR LRR domains 
The electron density of TDIF is clearly defined on the concave surface of LRR4–
LRR15 of TDR (Fig. 2-11, Fig. 2-13). TDIF adopts an extended conformation, with a kink 
around Gly6–Hyp7 at the middle of the peptide. The backbone of the TDIF peptide forms van 
der Waals interactions with the bulky side chains of TDR, such as Phe and Trp (Fig. 2-14 A–D). 
The interactions between TDIF and TDR can be divided into three parts: the N-terminal part 
(His1–Hyp4), the middle part (Ser5–Hyp7) and the C-terminal part (Asn8–Asn12; Fig. 2-14 A–
D). 
Arg421
Trp325
Phe351Ile329
Phe281
Tyr234
Phe161
Ser162
Arg423Phe401
Arg421
Trp325
Phe351Ile329
Phe281
Tyr234
Phe161
Ser162
Arg423Phe401
His1 His1
Hyp7Hyp7
Hyp4
Asn12 Asn12
Hyp4
Fig. 2-13 Electron density maps of the TDIF-binding site. Stereo views of the electron density 
maps of the TDIF-binding site of TDR. The FO – FC omit map calculated without TDIF (contoured 
at 3.0 σ) is shown as a green mesh, while the 2FO – FC electron density map (contoured at 1.5 σ) 
is shown as a blue mesh. TDIF and TDIF-interacting TDR residues are shown as orange and green 
sticks, respectively. 
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Fig. 2-14 TDIF recognition by TDR. A. The TDIF-interacting residues of TDR are shown in stick 
representations. TDIF, orange; TDR green. Hydrogen bonds, dashed green lines. B–D. Recognition of 
the middle part (residues 5–7) (B), the N-terminal part (residues 1–4) (C), and the C-terminal part 
(residues 10–12) (D) of TDIF by TDR. In B, TDR is shown in a ribbon (upper) and a surface 
representation (lower). The kink-recognition pocket, pink. E. Pull-down experiment using the 
biotinylated TDIF and TDR mutants. The C259A/C540S TDR mutant was used for crystallization, 
and other mutations were introduced to this construct. Proteins were mixed with Streptavidin beads 
in the presence or absence of biotinylated TDIF. The bound proteins were eluted with SDS sample 
buffer and analysed by SDS–PAGE. See also Fig. 2.5.A. F. Localization of TDR–CFP variants in 
Nicotiana benthamiana epidermis. Scale bar indicates 20 µm. G. TDIF responses in TDR mutated 
variants. TDIF responses were evaluated by measuring FRET efficiencies between TDR–CFP and 
BIN2–YFP. The boxplot diagram displays FRET efficiencies in incubations with or without 5 µM 
TDIF for 30 min. Significant differences according to the Student’s t-test are indicated by asterisks 
(P < 0.01; n = 15). 
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In the middle part, the kink around Gly6–Hyp7 is recognized by the pocket formed by 
Asp255 (LRR8), Phe279 (LRR9), Phe281 (LRR9) and Trp325 (LRR11) of TDR, in a 
shape-complementary manner (Fig. 2-14 B). To verify the importance of the TDIF kink 
recognition by TDR, pull-down assays were performed using biotinylated TDIF peptides. The 
results showed that the D255E mutation of TDR, which may change the size of the 
kink-recognition pocket, reduced its TDIF binding, as compared with those of wild-type TDR 
and the C259A/C540S mutant (Fig. 2-14 E, Fig. 2-7 A). Furthermore, a previous study showed 
that the G6A mutation abolished the TDIF activity64. These results suggest that the kink 
formation in TDIF and the kink-recognition pocket of TDR are critical for the TDR–TDIF 
interaction. A previous study reported that the post-transcriptional hydroxylation of Hyp7 is 
dispensable for the TDIF activity64. Consistently, the hydroxyl group of Hyp7 is not recognized 
by TDR, although the other moieties of Hyp7 form van der Waals interactions with the side 
chains of Phe279, Leu301 and Trp325 of TDR. Taken together, the central kink of the TDIF 
peptide is recognized by the kink-recognition pocket formed by the TDR LRR domains, through 
shape complementarity. 
2.6.4 Sequence-specific recognition of TDIF by TDR 
In the N-terminal part, the imidazole nitrogen of His1 of TDIF hydrogen bonds with 
the main-chain carbonyl groups of Ser187 (LRR5) and Gly210 (LRR6), and the N-terminal 
amino group and the carbonyl group of His1 of TDIF form further hydrogen bonds with the 
hydroxyl group of Ser162 (LRR4) of TDR. The Val3 side chain of TDIF interacts with the 
hydrophobic surface around Phe161 (LRR4) of TDR (Fig. 2-14 C). The results of the pull-down 
assay demonstrated that the F161A and S162A mutations of TDR decreased the TDIF binding, 
suggesting the importance of these interactions with the N-terminal part (Fig. 2-14 E, Fig. 2-7 
A). Moreover, a previous study reported that the H1A and V3A mutations in TDIF diminished 
the TDIF activity in planta64, suggesting the biological importance of the interactions observed 
in the crystal structure. In contrast, the side chains of Glu2 and Hyp4 are not recognized by 
TDR; the Glu2 side chain is disordered, while Hyp4 is solvent-exposed in the present crystal 
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structure. These observations are consistent with the previous study showing that both the 
E2A mutation and the Hyp4 to Pro substitution in TDIF do not affect the inhibitory activity 
against the tracheary element differentiation64. 
At the C-terminal part, the Asn12 carbonyl group of TDIF hydrogen bonds with the 
side chains of Arg421 and Arg423 of TDR (Fig. 2-14 D). The pull-down assay revealed that the 
R423A mutation reduced the TDIF-binding activity, while the R421A mutation slightly reduced 
it (Fig. 2-14 E). Consistent with the results from the in vitro assay, the R421A/R423A mutation 
abolished the responsiveness to TDIF in the reconstructed TDIF–TDR–BIN2 pathway in 
Nicotiana benthamiana leaves, confirming the importance of these TDR–TDIF interactions in 
the cellular context (Fig. 2-14 F, G). Moreover, a previous study showed that the N12A 
mutation of TDIF diminishes the TDIF activity64. These results suggest that the recognition of 
the C-terminal Asn residue of TDIF by Arg423 of TDR is critical for the TDR–TDIF signalling 
pathway in planta. The Ser162, Arg421 and Arg423 residues are conserved among the TDRs 
from other plants, implying that the TDIF-recognition mechanisms are also conserved among 
plant species (Fig. 2-15). Taken together, the N and C termini of TDIF are both recognized by 
TDR through sequence-specific hydrogen bonding interactions. 
2.7 Discussion 
2.7.1 Insight into the dimer formation of TDR 
In this chapter the crystal structure of the extracellular domain of TDR in complex 
with its ligand, TDIF, was determined. In conjunction with the functional analyses, it was 
revealed that the recognition mechanism of TDIF by TDR. Zhang et al.118 reported the crystal 
structure of TDR–TDIF, which is essentially identical to the structure determined here 
(root-mean-square deviation of 1.23 Å for 585 aligned Cα atoms; Fig. 2-16), confirming the 
functional relevance of the TDIF-recognition mechanism of TDR. In addition, their genetic 
complementation assays in Arabidopsis affirmed that the C-terminal recognition of TDIF by 
the positive charges of Arg421 and Arg423 in TDR is required for the in vivo function of TDR, 
in agreement with the results of our in vitro and in vivo assays. Moreover, Zhang et al. showed 
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that TDR forms a TDIF-dependent heterodimer with the extracellular LRR domain of SERK1, 
SERK2 and BAK1 (also known as SERK3) in a gel-filtration analysis, thereby indicating that 
SERK family proteins redundantly act as co-receptors of TDR119.  
AtTDR
     40        50        60               70        80        90       100       110      
AtTDR   L  L S K  L  P      W                 VWC W G  C   T Q  SL  S    SG I    RYL  L  LN SGN Q S L  S  F D    S S    I  DL RNL   P I         P L L T SG PSA Q KVPVNG.......QNDA VV DNV A V H R IQ SS LY L S
ZeTDR   L  L S K  L  P      W                 VWC W G  C   T Q  SL  S    SG I    RYL  L  LN SGN Q S   S D F      S  P   I  D  RNL   P    T       S V M L A K LYT HE KVVPKSGAGTNYSAPGS L VK D R H V I N T ANT G RF I Q
PtTDR   L  L S K  L  P      W                 VWC W G  C   T Q  SL  S    SG I    RYL  L  LN SGN  S L   D F D    S S  P     DL RNL   P I   T       PP Q I TF K SNT H NLSNTSGL.....IQEP IK N A A IT H V AE S VH L A
MtTDR   L  L S K  L  P      W                 VWC W G  C   T Q  SL  S    SG I    RYL  L  LN SGN Q  L  S D D    S   P   I  L    I   T       F IT I S I LNQLA ENPSDN.......HQDP R IT H K T I N NLKF I SPQ T TH I D
AtTDR
 120       130       140       150       160       170       180       190       200      
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PtTDR   G      F L  L  LDIS N F S FP GISKL  L  F A SN F G LP     L  LE L   GSYF G IP  YG   RLK  F  AI                 KF  N Y      E  RF   NLG     E  S  F    LD LLQP E GD RI H N N T T RV N T P K FVW E T R S L Y
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AtTDR
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MtTDR P   C  N L     F N F    P SL  C SL R R Q N LNG IP       N      S N F    P        L  LN S N N  G  IL   L   N     I N    S  P L DL   G I L  Y    I I K N VWF D N TNS S N T T V K QTLTLV TYL N N N K LK E...N Q I G
AtTDR
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Fig. 2-15 Multiple sequence alignment of the extracellular domains of TDRs from different 
plant species. “At”, “Ze”, “Pt” and “Mt” represent Arabidopsis thaliana, Zinnia elegans, 
Populus trichocarpa and Medicago truncatula, respectively. Residues involved in TDIF 
recognition are indicated by red triangles. Cys residues that form disulfide bonds are 
indicated by orange lines. 
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Fig. 2-16. Stereo views of the superimpositions of the current TDR structure (colored) and the 
reported TDR structure (gray). A. Superimpositions of the TDR–TDIF complex structures. B. 
Superimpositions of the TDIF peptide structures. 
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2.7.2 Comparison with known LRR-RKs structures 
A comparison of the TDR–TDIF complex structure with those of known plant 
LRR-RKs and their ligand complexes revealed the conserved structural features among the 
plant LRR-RK family members. The twisted superhelical structures and the N-terminal 
capping domain of the LRR domain of TDR are commonly observed in the other plant LRR-RK 
structures, including BRI1 and FLS2 (Fig. 2-17 A–C)106,107,109. In the LRR domains of these 
structures, the LxxLxL motif forms parallel β sheets, with their Leu residues facing towards 
the inner side of the molecule, to form the hydrophobic core in the proteins. Furthermore, the 
N- and C-terminal capping domains contribute to structural stabilization, by preventing the 
exposure of the hydrophobic core to the solvent116. Nonetheless, there are also notable 
structural differences between TDR and the other LRR-RKs. The LRR-RKs FLS2 and BRI1 
form ligand-dependent heterodimers with the co-receptor BAK1, mediated by their ligands, 
flg22 and brassinolide, respectively. In these structures, the ligands are sandwiched between 
the receptor and the co-receptor, thereby serving as molecular glue to stabilize the interaction 
(Fig. 2-17 B, C, Fig 2-18)109,120. Subsequently, the kinase domains of LRR-RK (BRI1 or FLS2) 
and a co-receptor (BAK1) trans-phosphoyrlate each other and consequently  enable to activate 
the downstream signaling events. In FLS2, LRR23–LRR26 are involved in the interaction with 
BAK1, while in BRI1, both LRR23–LRR25 and insertion domain between LRR21 and LRR22 
are involved in the ligand-mediated heterodimerization with BAK1. Notably, these structural 
features are absent in the LRR domains of TDR; the LRR domains of TDR are shorter than 
those of FLS2 and BRI1, and lack the insertion domain (Fig. 2-17 E, F). Moreover, the LRR 
domains of TDR and BRI1 have different curvatures. These structural differences suggest that 
TDR–TDIF form a heterodimer with BAK1 and also with SERK1 and SERK2, which shares 
about 70% sequence identity with BAK1 in Arabidopsis thaliana, in a manner distinct from 
those in the other BAK1-mediated receptors (that is, BRI1–brassinolide–BAK1 and FLS2–
flg22–BAK1; Fig. 2-17). 
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Fig. 2-17 Structural comparison of the plant LRR-RKs. A–C, Crystal structures of TDR–TDIF (A),    
BRI1–brassinolide–BAK1 (B) and FLS2–flg22–BAK1 (C). LRR-RKs, co-receptors and ligands are 
colored white, blue and orange, respectively. The insertion domain of BRI1, dark grey. D. N-terminal 
capping domains of TDR, FLS2 and BRI1. The disordered region (residues 61–64) is shown as a dashed 
line. Cys residues that form disulfide bonds, sticks. E, F, Superimposition of TDR onto the BRI1–
brassinolide–BAK1 (E) and the FLS2–flg22–BAK1 (F). TDR and the LRR-RK–ligand–BAK1 complexes 
are shown in olive and white, respectively. 
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2.7.3 Insight into the recognition mechanism of CLE family peptides 
The present crystal structure provides structural insights into the common 
recognition mechanism of the CLE family peptide hormones by their receptors. The 
kink-forming residues of TDIF (Gly6 and Hyp7) are highly conserved among the CLE family 
peptides (Table 2-1, Fig. 2-19 A). Previous studies reported that the G6A mutations in other 
CLE peptides also abrogate their activities, as observed in the case of TDIF64,121. Moreover, the 
residues in the kink-recognition pocket of TDR (Asp255 and Phe279) are well conserved among 
the CLE family peptide receptors, such as CLV1, BAM1/2/3 and SKM1 (Fig. 2-19 B). These 
observations suggest that the accommodation of the kinked peptide by the receptor pocket is 
the general interaction mechanism for the CLE family ligands and their receptors. In contrast, 
a previous study reported that several CLE family peptides other than TDIF do not interact 
with TDR66. The present crystal structure explains the mechanism by which TDR 
discriminates TDIF from other CLE peptides. At the C-terminal part of the molecular interface 
between TDR and TDIF, the Arg421 side chain of TDR hydrogen bonds with the Asn12 of TDIF. 
In the CLV3 peptide, this Asn12 residue is replaced with His, while Arg421 of TDR corresponds 
to Lys413 of CLV1, an LRR-RK receptor for the CLV3 peptide. Thus, it is possible that the 
interaction at the C-terminal part is important for the discrimination of the orthogonal ligand–
receptor pairs. Consistently, Arg421 is also conserved in other LRR-RKs, such as BAM1/2/3 and 
SKM1, which recognize the CLE peptides that possess Asn at position 12 (Table 2-1, Fig. 2-19 A, 
B)82,96,97. Concordant with these observations, a very recent study showed that synthetic  
Co-receptor
受容体Receptor
Ligand
Intracellular signalingKinase domains
P P
Fig. 2-18 Schematic model of the activation of plant LRR-RKs. LRR-RKs, co-receptors and 
ligands are colored gray, blue and red, respectively.  
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Fig. 2-19 Multiple sequence alignment of CLE family peptides and receptors in Arabidopsis 
thaliana. A. Sequence alignment of CLE family peptides. TDIF residues recognized by TDR are 
colored red. Conserved Pro/Hyp residues are colored blue. B. Sequence alignment of the 
extracellular domains of LRR-RKs that perceive CLE peptides. Arg421 and residues involved in 
peptide backbone recognition are indicated by purple and cyan triangles, respectively. 
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unnatural CLE peptide with amino acid substitution, KIN, can bind and activate both of TDR 
and CLV1 (Fig. 2-20)122. Furthermore, at the N-terminal part of the interface, the His1 side 
chain of TDIF is recognized by the main-chain carbonyl groups of Ser187 and Gly210 of TDR, 
and the Val3 side chain of TDIF interacts with the surface around Phe161 of TDR. These 
interactions can also explain the substrate specificity of TDR. A previous study reported that 
CLV3, CLE9, CLE19 and CLE46 do not interact with TDR66. In CLE46, Val3 of TDIF is 
replaced with His, showing that the bulky side chain of His cannot interact with the TDR 
surface around Phe161. In contrast, a previous study reported that CLE42 can act as a ligand 
of TDR in Arabidopsis92. Glu2 of TDIF is replaced with Gly in CLE42, consistent with the fact 
that the Glu2 side chain is not recognized by TDR. Collectively, the present crystal structure 
suggests that the central kink of the CLE peptides, including TDIF, offers a common platform 
for the recognition by the CLE peptide receptors, while the N- and C-terminal parts provide the 
sequence-specific readout for the cognate CLE receptors. 
 
2.8 Conclusion 
In conclusion, the structural and functional data revealed the recognition mechanism 
of TDIF by TDR, and provided insights into the recognition mechanism of the CLE family 
peptides by their cognate receptors. These findings may help pave the way for the rational 
engineering of the TDR–TDIF axis, to improve biomass production. Actually, the 
aforementioned example of the designed synthetic CLE peptide KIN122 agreed well with the 
sequence–structure relationship, which was proposed in the current study. The KIN peptide is 
shown to have the bioactivity beyond the original subfamily by interacting with multiple 
CLV3 RTVPSGPDPLHH CLV1 
KIN  RKVPSGPDPIHN CLV1, TDR
TDIF  HEVPSGPNPISN TDR
Peptide Sequence   Receptor
(Hirakawa et al., 2017)
Fig. 2-20 Sequence and specificity of the synthetic bifunctional CLE peptide, KIN. 
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receptors. These observations suggest the feasibility of the structure-based rational 
engineering of the TDR–TDIF axis. 
The crystal structure of TDR–TDIF–SERK2 was reported by in 2016 by Zhang et al119. 
In their study, it is shown that TDR physically interacts SERK2 as well as SERK1 to form a 
functional complex, expanding the discussion in 2.7.1. Genetic analysis using Arabidopsis 
revealed that SERK1, SERK2 and BAK1 redundantly regulate procambial cell formation as 
co-receptors of TDR. In the crystal structure of TDR–TDIF–SERK2 complex, the structure of 
TDR–TDIF (rmsd of 0.81 Å for 589 aligned Cα atoms; Fig. 2-21 A, B), suggesting that SERK2 
binding does not induce significant structural change in TDR–TDIF. In the structure, TDIF 
mediates the binding between TDR and SERK2 with its C-terminal sandwiched between them. 
These observations indicate that binding between TDR and TDIF is prerequisite for the 
formation of TDR–TDIF–SERK2 ternary complex, similar in flg22-mediated FLS2–BAK1 
interaction and brassinolide-mediated BRI1–BAK1 interaction. Taken together, it is proposed 
that TDIF works as a molecular glue to mediate the connection between the extracellular 
domains of TDR–co-receptor, and subsequently mediate the connection interaction between 
intracellular kinase domains to somehow trigger the downstream signaling. 
More recently, the crystal structure of PXL2 (PXY-like 2)–CLE42 complex was 
reported123. PXL2 is a close homolog of TDR which shares 62% sequence similarity with TDR, 
and there is only one difference in amino acid sequence between TDIF and CLE42 (TDIF, 
HEVPSGPNPISN and CLE42, HGVPSGPNPISN). Concordant with these observations, 
structural features found in PXL2–CLE42 interaction are apparently common with those in 
TDR–TDIF, although close inspection can not be performed because the structure data has not 
been released yet. Taken together, observations in this study are well supported by the latest 
studies. 
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Fig. 2-21 Structure of the TDR–TDIF–SERK2 complex. A. Superimpositions of the current 
TDR–TDIF complex structure (colored) and the reported TDR–TDIF–SERK2 structure (gray, 
PDB ID 5GQR). B. TDR, SERK2 and TDIF are colored white, blue and orange, respectively. 
C. The TDR–TDIF–SERK2 interactions of the boxed region in (B). The TDIF-interacting 
residues of TDR and SERK2 are shown in stick representations. TDIF, orange; TDR, gray; 
SERK2, blue. Hydrogen bonds, dashed green lines. 
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General Discussion 
 In this dissertation, I focused on cell surface proteins of higher eukaryotes, and 
analyzed the X-ray crystal structure of the complex with their ligands in order to elucidate 
their ligand recognition mechanism and substrate specificity. Expression of these proteins in 
eukaryotic cells in the secreted form in this study enabled us to observe the common features of 
these proteins such as N-linked glycans and disulfide bonds to keep them stable. Cell surface 
proteins are sometimes targeted for drug discovery, and clarifying the molecular mechanisms 
for the recognition of foreign body recognition by them is also indispensable for understanding 
essential biological phenomena. It is expected that deepening the understanding of the ligand 
recognition mechanism of these proteins will lead to an understanding of the structural basis 
in which each protein is involved in its own physiological functions. 
In Chapter 1, I determined the crystal structure of the extracellular 
phosphodiesterase ENPP6, a choline metabolizing enzyme of vertebrate animals, in complex 
with a reaction product, phosphocholine. The obtained structure, biochemical analysis and cell 
physiological analysis revealed that ENPP6 metabolizes choline-containing phosphodiester to 
produce phosphocholine, so that choline can be taken up into cells. In addition, structural 
comparison provided insights into the characteristics of the pocket structure that determines 
the substrate specificity of the ENPP family protein. 
In Chapter 2, the crystal structure of a plant hormone receptor TDR was determined 
in complex with its ligand TDIF at a resolution of 3.0 Å and the structure of the side chain of 
the amino acid residue of TDIF was cleary defined. The obtained structure and mutant 
analysis revealed that TDIF forms a kink, which is recognized by the pocket of TDR in a 
shape-complementary manner. Furthermore, TDR specifically interacts with amino acid 
residue of TDIF at the N-terminal and C-terminal. Sequence comparison suggested that TDR 
distinguishes TDIF from other CLE family peptides by this difference in the terminal part. 
Structural comparison between TDR and known LRR-RKs gave suggestions for both universal 
features and diversity features in plant LRR-RK structures. 
 While most of the cell surface receptors in animals are G-protein-coupled receptors 
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(GPCR), most of them in plants are enzyme-coupled recepors. In animals, most of 
enzyme-coupled cell surface receptors are receptor tyrosine kinase (RTK), which are rarely 
found in plants. Instead, the largest class of enzyme-coupled cell surcface receptor in plants is 
transmembrane receptor serine/threonine kinase, among which LRR-RKs with a tandem array 
of extracellular LRR are most abundant types. Whereas the identification, functional analysis, 
and characterization of ligands of them are being advanced, their structural characterization is 
relatively delayed. The structures obtained in this work and the findings derived from them 
are expected to help structural and functional analysis of the plant LRR-RK in the future.  
In this study, I revealed the substrate recognition mechanism of cell surface proteins 
of higher eukaryotes at sub-nanometer resolution, revealing the structural basis that each 
protein exerts its physiological function. In addition, the various methods used in the course of 
this research may help research to elucidate the structure of other extracellular proteins in the 
future. 
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